This is a review about E-cadherin, based on 512 published articles (read how Labome selects the articles), using E-cadherin antibody in all methods. It is aimed to help Labome visitors find the most suited E-cadherin antibody.
E-cadherin synonym: Arc-1; CD324; CDHE; ECAD; LCAM; UVO; CAM 120/80; E-Cadherin; E-cadherin 1; cadherin 1, E-cadherin (epithelial); cadherin 1, type 1; cadherin 1, type 1, E-cadherin (epithelial); calcium-dependent adhesion protein, epithelial; cell-CAM 120/80; epithelial cadherin; uvomorulin

Invitrogen
mouse monoclonal (HECD-1)
  • IC; human
In order to test if lysophosphatidic acid stimulates uPAR expression and activity in ovarian epithelial cancer cells, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples. Anticancer Res (2015) ncbi
mouse monoclonal (4A2C7)
  • ChIP; mouse
In order to investigate E-cadherin expression and its relationship to those transcriptional repressors in the progression from carcinoma 'in situ' to invasion to lymph node metastasis in spontaneously arising canine invasive micropapillary carcinoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in chromatin immunoprecipitation on mouse samples. J Comp Pathol (2015) ncbi
mouse monoclonal (HECD-1)
  • WB; mouse
In order to investigate the role of LZTFL1 in lung oncogenesis, Invitrogen E-cadherin antibody (Life Technologies, 13-1700) was used in western blot on mouse samples. Oncogene (2015) ncbi
mouse monoclonal (4A2C7)
  • WB; human
In order to determine the role of growth factors in EMT, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in western blot on human samples. PLoS ONE (2015) ncbi
mouse monoclonal (7H12)
  • WB; mouse
In order to investigate the involvement of doublecortin-like kinase 1 in colitis, Invitrogen E-cadherin antibody (Life Technologies, MA5-15711) was used in western blot on mouse samples. PLoS ONE (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human
In order to review cases and literature involving solid-pseudopapillary neoplasm of the pancreas, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples. Indian J Pathol Microbiol (2015) ncbi
mouse monoclonal (HECD-1)
  • IC; human
In order to assess the involvement of lysophosphatidic acid in epithelial ovarian carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples. J Biol Chem (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; tbl 2
In order to characterize the morphological features and mucin expression profile of breast carcinomas with signet-ring cell differentiation, Invitrogen E-cadherin antibody (Zymed/Invitrogen,, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Pathol Res Pract (2015) ncbi
mouse monoclonal (HECD-1)
  • WB; mouse
In order to discuss the role and regulation of cell-cell adhesion in prostate cancer aggressiveness, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in western blot on mouse samples. Cancer Med (2015) ncbi
mouse monoclonal (4A2C7)
  • IC; human; 1:200
In order to test if pomegranate juice protects trophoblasts from hypoxia-induced apoptosis by modulating NDRG1 expression, Invitrogen E-cadherin antibody (Life Technologies, 18-0223) was used in immunocytochemistry on human samples at 1:200. Placenta (2015) ncbi
mouse monoclonal (4A2C7)
  • IC; mouse; fig 7
In order to identify an integrin-independent role of ERI complexes during keratinocyte differentiation, Invitrogen E-cadherin antibody (Life Technologies, 33-4000) was used in immunocytochemistry on mouse samples (fig 7). Mol Biol Cell (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; dog; 1:25
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on dog samples at 1:25. Res Vet Sci (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:100
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100. Clin Epigenetics (2015) ncbi
mouse monoclonal (NCH-38)
  • WB; human
Invitrogen E-cadherin antibody (Chemicon, MA5-12547) was used in western blot on human samples. Oncol Lett (2015) ncbi
mouse monoclonal (SPM471)
  • IHC; human; 1:300
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, Invitrogen E-cadherin antibody (Thermo Scientific, SPM471) was used in immunohistochemistry on human samples at 1:300. Gynecol Oncol (2015) ncbi
mouse monoclonal (DH01 (DCS-266))
  • WB; human
In order to study the effect of MASTL on cyclin B1 degradation and its mechanism, Invitrogen E-cadherin antibody (Neomarkers, MS-1116-P1) was used in western blot on human samples. Biol Open (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:200
In order to identify and characterize vessels that encapsulated tumor clusters in hepatocellular carcinoma sections, Invitrogen E-cadherin antibody (Life Technologies, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hepatology (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; 1:1200; fig 2
In order to report and characterize an unusual case of a microcystic stromal tumor of the ovary with a beta-catenin mutation, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:1200 (fig 2). Int J Gynecol Pathol (2015) ncbi
mouse monoclonal (DH01 (DCS-266))
  • WB; human; 1:500
In order to explore how Nek2 isoform A affects anaphase-promoting complex/cyclosome containing Cdc20, Invitrogen E-cadherin antibody (Neomarkers, MS1116-p1) was used in western blot on human samples at 1:500. J Cell Sci (2015) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:100
  • WB; human; 1:500
In order to examine Notch localization and activation in non-small cell lung cancer, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in western blot on human samples at 1:500. J Hematol Oncol (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; cat; 1:50
In order to assess the proteome in the urothelium of cats diagnosed with feline interstitial cystitis and compare it to the proteome of patients with human interstitial cystitis/bladder pain syndrome, Invitrogen E-cadherin antibody (Invitrogen, 18-0223) was used in immunohistochemistry - paraffin section on cat samples at 1:50. J Urol (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples. BMC Gastroenterol (2015) ncbi
mouse monoclonal (SPM471)
  • IHC-P; human; 1:150
In order to study the regulatory mechanism of beta-catenin on tumor metastasis, Invitrogen E-cadherin antibody (Thermo Fisher Scientific, SPM471) was used in immunohistochemistry - paraffin section on human samples at 1:150. Exp Ther Med (2015) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:3000
Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:3000. Hum Pathol (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC; human
Invitrogen E-cadherin antibody (Zymed/Invitrogen, 4A2C7) was used in immunohistochemistry on human samples. BMC Vet Res (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC-F; human
In order to study the expression and dynamics of the tight junction proteins during the disruption of desmosomes in Hailey-Hailey disease and Darier's disease lesions, Invitrogen E-cadherin antibody (Zymed Laboratories, 33-4000) was used in immunohistochemistry - frozen section on human samples. Dermatol Reports (2009) ncbi
mouse monoclonal (4A2C7)
  • WB; mouse
In order to elucidate the molecular mechanisms underlying paranodal junction assembly, Invitrogen E-cadherin antibody (Life Technologies, 4A2C7) was used in western blot on mouse samples. Nat Neurosci (2014) ncbi
mouse monoclonal (HECD-1)
  • IC; human; 1:100; fig 4
In order to determine the localization of NLRP7 and KHDC3L in human oocytes and preimplantation embryos, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunocytochemistry on human samples at 1:100 (fig 4). Hum Reprod (2015) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:800
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:800. Endocr Pathol (2015) ncbi
mouse monoclonal (HECD-1)
  • IC; human
In order to study the effect of HNF4alpha on the chemosensitivity to oxaliplatin and 5-FU in renal cell carcinoma, Invitrogen E-cadherin antibody (Life Technologies, 13-1700) was used in immunocytochemistry on human samples. J Pharm Sci (2014) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:3000
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry on human samples at 1:3000. PLoS ONE (2014) ncbi
mouse monoclonal (SPM471)
  • IHC-P; human; 1:100; fig 3
In order to assess the diagnostic role of CD44 and E-cadherin in atypical leiomyoma and leiomyosarcoma, Invitrogen E-cadherin antibody (Thermo Scientific, SPM471) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). J Obstet Gynaecol (2015) ncbi
rabbit polyclonal
  • IHC; human; 1:400
In order to develop a 3D culturing system to mimic the tumor microenvironment using transglutaminase-cross-linked gelatin gel (Col-Tgel), Invitrogen E-cadherin antibody (Thermoscientific, PA5-32178) was used in immunohistochemistry on human samples at 1:400. PLoS ONE (2014) ncbi
mouse monoclonal (HECD-1)
  • IHC; mouse
Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry on mouse samples. Head Neck (2015) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 3
In order to identify serines in the beta-catenin-binding domain of E-cadherin that are phosphorylated, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 3). Mol Biol Cell (2014) ncbi
mouse monoclonal (HECD-1)
  • FC; human; 1:50
In order to investigate the effect of glycosylation on tumor cell adhesion and invasion and its mechanism, Invitrogen E-cadherin antibody (Zymed Labs, HECD-1) was used in flow cytometry on human samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; mouse
Invitrogen E-cadherin antibody (Zymed Laboratories Inc, HECD-1) was used in immunohistochemistry - paraffin section on mouse samples. Clin Cancer Res (2014) ncbi
mouse monoclonal (HECD-1)
  • WB; human
  • IC; human
In order to study the localization of Helicobacter pylori on the apical surface of gastrointestinal epithelium and its damaging effect on the mucosal barrier, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in western blot on human samples and in immunocytochemistry on human samples. Helicobacter (2014) ncbi
mouse monoclonal (4A2C7)
  • WB; rat; 1:1000
In order to characterize transmural intestinal wall permeability in severe ischemia after enteral protease inhibition, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:25
Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:25. Am J Clin Pathol (2014) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human
Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in neutralization on human samples. J Cell Sci (2014) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to study the release of soluble giant cadherin Fat1 from pancreatic cancer cells, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in western blot on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:2000
Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Hum Pathol (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; dog; 1:50
In order to determine the expression of E-cadherin, beta-catenin, and Ki-67 in canine prostatic lesions, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on dog samples at 1:50. Pak J Biol Sci (2013) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:100; fig 7
In order to explore interactions between human tumor cells and a humanized bone microenvironment, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry on human samples at 1:100 (fig 7). Clin Exp Metastasis (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human
  • IC; human
  • WB; human; 1:1000
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples, in immunocytochemistry on human samples, and in western blot on human samples at 1:1000. Br J Cancer (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; 1:400
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:400. Hum Pathol (2014) ncbi
not indicated
  • WB; human
Invitrogen rat anti-E-Cadherin (ECCD-2; 13-1900) was used to perform western blot in order to study the role for TRAF4, a novel phosphoinositide-binding protein in modulating tight junctions and promoting cell migration.PLoS Biol (2013) ncbi
mouse monoclonal (4A2C7)
  • IC; Clostridium difficile; fig 5
In order to describe how Clostridium difficile toxin A and B contribute to colonization, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunocytochemistry on Clostridium difficile samples (fig 5). J Infect Dis (2014) ncbi
mouse monoclonal (4A2C7)
  • IC; dog; fig 3
  • WB; dog; fig 7
In order to study the molecular mechanisms underlying the reversible effects of capsaicin on tight junction permeability, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunocytochemistry on dog samples (fig 3) and in western blot on dog samples (fig 7). PLoS ONE (2013) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200; fig 5
In order to study the efficacy and tolerability of the irreversible tyrosine kinase inhibitor dacomitinib in human bladder cancer models, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5). Mol Med (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC; human
In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples. Fetal Pediatr Pathol (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:100
In order to assess the prognostic significance of the epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Clin Pathol (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC; dog
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on dog samples. J Comp Pathol (2014) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:200; fig 9
In order to describe the magnetic levitation method of 3D cell culturing, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry on human samples at 1:200 (fig 9). Nat Protoc (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC; mouse; fig 1
In order to report that upregulation of BCL2 is not involved in lobular breast carcinogenesis, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC; pig; fig 2
In order to examine the effects of Helicobacter spp. infection on gastric morphology in pigs, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on pig samples (fig 2). J Comp Pathol (2013) ncbi
mouse monoclonal (4A2C7)
  • WB; mouse; fig 4
In order to report that Snai1 inhibits beta4 transcription by increasing repressive histone modification and that Id2 regulates Snai1, Invitrogen E-cadherin antibody (Invitrogen, 334000) was used in western blot on mouse samples (fig 4). Mol Cell Biol (2013) ncbi
mouse monoclonal (4A2C7)
  • WB; human; 1:1000
In order to investigate the regulation of ZO-1 by p38delta mitogen-activated protein kinase in differentiating human epidermal keratinocytes, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in western blot on human samples at 1:1000. Arch Dermatol Res (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:50; tbl 1
In order to reduce the inter-observer variability of the calculated proliferative index observed in breast cancer samples using a cocktail of antibodies against E-Cadherin and Ki-67, Invitrogen E-cadherin antibody (Zymed laboratories, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Pathol Oncol Res (2013) ncbi
mouse monoclonal (HECD-1)
  • WB; mouse; fig 1
In order to elucidate the role of Snail in pancreatic cancer development, Invitrogen E-cadherin antibody (Life Technologies, 13-1700) was used in western blot on mouse samples (fig 1). Mol Cancer Res (2013) ncbi
mouse monoclonal (HECD-1)
  • WB; mouse; fig 2
In order to study listeriosis in wild-type mice using InlA that has been "murinized" to interact with mouse Ecad, Invitrogen E-cadherin antibody (Invitrogen, clone HECD-1) was used in western blot on mouse samples (fig 2). PLoS Pathog (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; 1:200; fig 1
In order to investigate the contribution of p120 to breast cancer metastasis, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:200 (fig 1). Cancer Res (2013) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200; fig 1
In order to test if EMT-related proteins alterations are associated with the clinicopathological features and prognosis in lung adenocarcinoma, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Diagn Pathol (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 1
In order to study E-cadherin dysregulation in gastric cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Biochim Biophys Acta (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; mouse; 1:50; fig 2
In order to discuss the roles of E-cadherin and beta-catenin in cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2). Urol Int (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:100; fig 1
In order to compare expression of Dsg3, E-cadherin, and syndecan-1 in acantholytic squamous cell carcinoma and squamous cell carcinoma, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Am J Clin Pathol (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; Japanese crane; fig 4
In order to describe the cancers found in a red-crowned crane, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on Japanese crane samples (fig 4). J Vet Med Sci (2013) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:100; fig 1
In order to examine E-cadherin-negative ductal carcinoma, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry on human samples at 1:100 (fig 1). Histopathology (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:100; fig 1
In order to study the relationship between cyclooxygenase enzymes and E-cadherin in the prediction of survival in optimally cytoreduced serous ovarian cancer patients, Invitrogen E-cadherin antibody (Zymed, 4A2c7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Asian Pac J Cancer Prev (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-F; human; 1:200; fig 5
In order to ask if cross talk between stromal and cancerous cells correlates with the invasive phenotype of breast tumor cells, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 5). PLoS ONE (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; fig 3
In order to identify new genes involved in gastric cancer, Invitrogen E-cadherin antibody (Invitrogen, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 3). J Pathol (2013) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 1
In order to assess if the EphA2/ephrin-A1 signaling axis is altered in psoriasis, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in western blot on human samples (fig 1). J Invest Dermatol (2013) ncbi
mouse monoclonal (SHE78-7)
  • WB; human; fig 5
In order to report that oncogenic B-RAF(V600E) regulates genes associated with epithelial-mesenchymal transition in normal cutaneous human melanocytes, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in western blot on human samples (fig 5). J Invest Dermatol (2013) ncbi
mouse monoclonal (SHE78-7)
  • IC; human; fig 3
In order to explore the collective cell behavior of migrating human corneal limbal-epithelial cell sheets, Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in immunocytochemistry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human; 2 ug/ml; fig 2
In order to study the contribution of extracellular vesicles to the epithelial-to-mesenchymal transition to cancer, Invitrogen E-cadherin antibody (Invitrogen, clone SHE78-7) was used in neutralization on human samples at 2 ug/ml (fig 2). J Biol Chem (2012) ncbi
mouse monoclonal (HECD-1)
  • WB; human; 2 ug/ml
In order to discuss methods to identify yessotoxin, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in western blot on human samples at 2 ug/ml. Chemosphere (2013) ncbi
mouse monoclonal (SHE78-7)
  • IC; human; 5 ug/ml; fig 3
In order to elucidate the relationship between the multiple drug resistance and invasion, Invitrogen E-cadherin antibody (Zymed, 13-5700) was used in immunocytochemistry on human samples at 5 ug/ml (fig 3). Eur Rev Med Pharmacol Sci (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; fig s3
In order to characterise novel sinonasal undifferentiated carcinoma cell lines, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry on human samples (fig s3). Clin Cancer Res (2012) ncbi
mouse monoclonal (4A2C7)
  • WB; human; fig 3
In order to report that lethal toxin targets alveolar epithelial cells, Invitrogen E-cadherin antibody (Invitrogen, 4A-2C7) was used in western blot on human samples (fig 3). Infect Immun (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:100; fig 6
In order to evaluate the effectiveness of VEGF restriction on orthotopic tumor growth and elucidate the mechanism of treatment resistance, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6). Neuro Oncol (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; 1:50; fig 2
In order to examine the effects of calcium and vitamin D on adenomatous polyposis coli, beta-catenin, and E-cadherin expression in patients with sporadic colorectal adenoma, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry on human samples at 1:50 (fig 2). Cancer Prev Res (Phila) (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200; fig 4
In order to examine the effects of rapamycin treatment using an organotypic culture of human skin explants, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4). Arch Dermatol Res (2013) ncbi
mouse monoclonal (4A2C7)
  • IHC; mouse; 1:150
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on mouse samples at 1:150. Environ Toxicol (2014) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:400; fig 1
In order to examine E-cadherin expression in phyllodes tumors, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Hum Pathol (2012) ncbi
mouse monoclonal (4A2C7)
  • IC; mouse; fig 2
In order to investigate the roles of ZO-1 in mouse embryonic stem cells, Invitrogen E-cadherin antibody (Zymed, 18-0223) was used in immunocytochemistry on mouse samples (fig 2). Stem Cells (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; dog; fig 2
In order to study the expression and localization of E-cadherin in canine round cell tumors, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on dog samples (fig 2). Vet J (2012) ncbi
mouse monoclonal (HECD-1)
  • IC; human; fig 4
In order to examine distribution of the GCTM-5 antigen in normal tissues and disease states and characterize the antigen biochemically, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples (fig 4). Stem Cells (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200; tbl 1
In order to correlate the of CADM4, E-cadherin, and Ki-67 in colorectal adenocarcinomas, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). J Clin Pathol (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; 1:200; fig 2
In order to study the association of nuclear Kaiso with high grade and invasive triple negative breast cancers and cytoplasmic Kaiso with invasive lobular carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:200 (fig 2). PLoS ONE (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:100; fig 1
In order to correlate the expression of cyclin D1 to various breast cancer features, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Hum Pathol (2012) ncbi
mouse monoclonal (HECD-1)
  • IC; human; fig 4
  • WB; human; fig 2
In order to develop and characterize a model for Hailey-Hailey disease using normal keratinocytes, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 2). Exp Dermatol (2012) ncbi
mouse monoclonal (HECD-1)
  • IC; human; fig 1
In order to investigate the effect of lysophosphatidic acid on E-cadherin junctional integrity, Invitrogen E-cadherin antibody (Zymed, hecd-1) was used in immunocytochemistry on human samples (fig 1). J Oncol (2012) ncbi
mouse monoclonal (4A2C7)
  • IC; human; fig 6
In order to elucidate the relationship between normal fibroblasts and epithelial cancer cells, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on human samples (fig 6). Anticancer Res (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:50; tbl 2
In order to examine APC/beta-catenin signaling pathway members as biomarkers for the risk of colorectal neoplasms, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Cancer Epidemiol Biomarkers Prev (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:50; fig 1
In order to assess the risk of relapse for lobular carcinoma in situ patients, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Breast (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 3
In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (HECD-1)
  • IC; human; 1:2500; tbl 1
In order to develop and characterize a new 3-D spheroid cell culture system that mimics solid tumors, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 1:2500 (tbl 1). Exp Cell Res (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:25; fig 1
In order to describe a histologic, molecular, and immunophenotypic analysis of patients with sporadic early-onset of colorectal carcinoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 1). Mod Pathol (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; fig 3
In order to identify and describe Franceschetti corneal dystrophy, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on human samples (fig 3). Am J Ophthalmol (2012) ncbi
mouse monoclonal (4A2C7)
  • IC; dog; fig 1
In order to examine the effect of treating epithelial cells with an inhibitor of the lipid kinase PIKfyve, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunocytochemistry on dog samples (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 1
In order to investigate the case of a boy with psychomotor delay and dysmorphic features, Invitrogen E-cadherin antibody (Zymed, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Gene (2012) ncbi
mouse monoclonal (HECD-1)
  • IC; human; fig 1
In order to investigate the involvement of the tumor microenvironment in the epigenetic control of genes critical to cancer progression, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunocytochemistry on human samples (fig 1). Epigenetics (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; fig 2
In order to characterize pulmonary adenocarcinoma with a micropapillary pattern samples, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on human samples (fig 2). Histopathology (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 1
In order to discuss the role of MLH1 in gastric cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). BMC Gastroenterol (2011) ncbi
mouse monoclonal (HECD-1)
  • IHC-F; human; fig 3
In order to establish and characterize a three-dimensional organotypic model of the human airway mucosa, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - frozen section on human samples (fig 3). Am J Physiol Lung Cell Mol Physiol (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:2500; tbl 3
In order to study the effect of contraceptive choices on cervical intraepithelial neoplasia, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (tbl 3). Contraception (2012) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 1
In order to study the EGF-induced, ADAM10-dependent shedding of E-cadherin by prostate epithelial cells, Invitrogen E-cadherin antibody (Invitrogen, clone HECD-1) was used in western blot on human samples (fig 1). Cell Signal (2012) ncbi
mouse monoclonal (HECD-1)
  • IC; mouse; fig 5
In order to test if CDH11 is increased in pulmonary fibrosis and contributes its development, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on mouse samples (fig 5). FASEB J (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC; mouse; fig 1
In order to investigate how Listeria monocytogenes crosses the epithelium, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry on mouse samples (fig 1). J Exp Med (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 1
In order to test if miRNA dysregulation is detected during progression from lobular carcinoma in situ to invasive lobular carcinoma, Invitrogen E-cadherin antibody (Zymed/Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). J Pathol (2012) ncbi
mouse monoclonal (SHE78-7)
  • IC; human; fig 6
  • IP; human; fig 5
In order to study the effect of alpha-catenin-p120 interactions, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in immunocytochemistry on human samples (fig 6) and in immunoprecipitation on human samples (fig 5). Mol Biol Cell (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; pig; 1:50; fig 5
In order to examine the effects of mycotoxins on the intestinal function of pigs, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on pig samples at 1:50 (fig 5). Br J Nutr (2012) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; fig 6
  • WB; human; 1:500; fig 3
In order to test in endothelial cells contribute to the epithelial to mesenchymal transition, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples (fig 6) and in western blot on human samples at 1:500 (fig 3). PLoS ONE (2011) ncbi
mouse monoclonal (HECD-1)
  • WB; human; 1:1000; fig 1
In order to identify cell surface protein biomarkers that discriminate between low-risk adenomas and normal colons from high-risk adenomas and colorectal cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:1000 (fig 1). Gut (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:500; fig 7
  • IHC-P; mouse; 1:500; fig 7
In order to determine the role of kindlin-1 in cancer, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 7) and on mouse samples at 1:500 (fig 7). J Natl Cancer Inst (2011) ncbi
mouse monoclonal (HECD-1)
  • IHC-F; human; 1:300; tbl 1
In order to discuss immunohistochemical analysis of the olfactory epithelium, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry - frozen section on human samples at 1:300 (tbl 1). Laryngoscope (2011) ncbi
mouse monoclonal (HECD-1)
  • IC; human; fig 2
In order to discuss the contribution of epithelial-to-mesenchymal transition to invasive and metastatic carcinomas, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples (fig 2). Mol Cancer (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 4
In order to establish a mouse model to study choriocarcinoma, Invitrogen E-cadherin antibody (ZYMED, 334000) was used in immunohistochemistry - paraffin section on human samples (fig 4). Am J Pathol (2011) ncbi
mouse monoclonal (4A2C7)
  • IC; dog; 1:25; fig 1
In order to demonstrate that ESCRT proteins are required to maintain polarity in mammalian epithelial cells, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunocytochemistry on dog samples at 1:25 (fig 1). Mol Biol Cell (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC; mouse; fig 2
In order to establish and characterize a new cell line derived from the kidney of a bank vole, Myodes glareolus, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig 2). Virol J (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC; mouse; fig 3
In order to generate and characterize a new cell line derived from a head and neck squamous cell carcinoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig 3). Oral Oncol (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC; mouse; fig s3
In order to determine the role of NRP2 in mouse mammary gland development, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig s3). Development (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 2
In order to investigate the relationship between gastric cancer and renal cell carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 2). Oncol Rep (2011) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:2500; tbl 1
In order to investigate the interactions among LRIG1, LRIG2, and other cancer markers as diagnostics in CIN, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (tbl 1). Gynecol Oncol (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 1
In order to investigate the relationship between endothelium-coated tumor clusters and severity of liver cancer patients, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Cancer (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; fig 4
In order to examine barrier function in the esophageal epithelium of patients with gastroesophageal reflux disease, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry on human samples (fig 4). Am J Gastroenterol (2011) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; fig 4
In order to examine barrier function in the esophageal epithelium of patients with gastroesophageal reflux disease, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry on human samples (fig 4). Am J Gastroenterol (2011) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:100; fig 1
In order to study the relationship between atypical ductal mammary hyperplasia and malignant neoplastic transformation in dogs, Invitrogen E-cadherin antibody (Zymed/Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Vet Pathol (2012) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; rat; 1:120; fig 7
In order to investigate the contribution of B12 to inflammatory bowel disease pathogenesis, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on rat samples at 1:120 (fig 7). J Cell Mol Med (2011) ncbi
mouse monoclonal (HECD-1)
  • WB; human; 1:1000; fig 5
In order to use the SW620 secretome to identify novel biomarker candidates, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples at 1:1000 (fig 5). Proteomics Clin Appl (2007) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:100; tbl 1
In order to characterize the expression of a number of proteins in tissues from pseudomyxoma peritonei patients, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Hum Pathol (2010) ncbi
rabbit polyclonal
  • WB; human
Invitrogen polyclonal anti-Cdh1 was used to perform western blot in order to show that Skp2 phosphorylation by Akt1 promotes Skp2 to localize in cytoplasm and impairs APCCdh1-mediated Skp2 destructionNat Cell Biol (2009) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 2
In order to assess the sensitivity of 18 squamous cell carcinoma of the head and neck cell lines to gefitinib, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples (fig 2). J Pathol (2009) ncbi
not indicatedThermo Fischer Scientific siRNAs for Cdh1 was used to perform RNA interference in order to study the control of claspin stability.J Cell Biol (2009) ncbi
not indicated
  • WB; human
Lab Vision mouse monoclonal anti-Cdh1 antibody was used in western blot to investigate the regulation of Cdc20 stability during SAC activation in mammalian cells and explore the contribution of spindle checkpoint proteins to Cdc20 stability.Cell Cycle (2009) ncbi
not indicated
  • IP; human
Invitrogen monoclonal anti-E-cadherin antibody was used in immunoprecipitation in order to demonstrate that oncogenic K-Ras can increase proliferation and decrease cell junctionsMol Biol Cell (2009) ncbi
not indicated
  • Neut; human
Invitrogen rat monoclonal anti-E-cadherin antibody (ECCD-2) was used in blocking or activating expriments to study the role for RhoE in keratinocyte differentiation and stratificationMol Biol Cell (2009) ncbi
not indicated
  • IHC; human
Zymed E-cadherin antibody (1:75) was used in immunohistochemistry in order to find marker for a clear distinction between acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcomaHead Face Med (2008) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:200; tbl 2
In order to study the genomic and immunophenotypical features of pure invasive micropapillary carcinomas, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry on human samples at 1:200 (tbl 2). J Pathol (2008) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:200; tbl 2
In order to characterize pleomorphic lobular carcinomas, Invitrogen E-cadherin antibody (Zymed, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). J Pathol (2008) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:100
In order to examine the expression and localization of the BRCA1 protein and assess its prognostic value in breast carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2008) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human; 10 ug/ml; fig 5
In order to investigate the role of P-cadherin in bladder transitional cell carcinomas, Invitrogen E-cadherin antibody (Zymed, 13-5700) was used in neutralization on human samples at 10 ug/ml (fig 5). J Pathol (2008) ncbi
not indicated
  • WB; human
  • IHC; human
Zymed anti-E-cadherin antibody was used to perform western blot and immunohistochemistry in order to study the acinar polarity defects and cystic neoplasms induced by Lkb1-deficient in pancreas.Mol Cell Biol (2008) ncbi
not indicated
  • WB; human
Zymed Laboratories anti-E-cadherin antibody was used in western blot in order to demonstrate that cadherin-mediated intercellular adhesion induces STAT signaling that may modulate cell survival and resistance to apoptosis during tumor progression in HNSCC cells.Exp Cell Res (2008) ncbi
not indicated
  • WB; human
  • IC; human
Zymed Laboratories E-cadherin monoclonal antibody was used at 1:1,000 for immunofluorescence and western blotting to study the induction of tumorigenesis and enhancement of cell motility of prostate epithelial cells by constitutively activated Stat3 through integrin beta 6.Mol Cell Biol (2007) ncbi
not indicated
  • IC; human
Zymed E-cadherin antibody was used in immunocytochemistry to evaluate the expression of Sox1 and Pax6 proteins during critical stages of lens morphogenesis, particular focus on fiber cell differentiation.Gene Expr Patterns (2007) ncbi
not indicated
  • IC; human
Zymed anti E-cadherin antibody was used in immunocytochemistry to identify a novel signal in the cytoplasmic tail of the Na+:HCO3- cotransporter NBC1 that mediates basolateral targetingAm J Physiol Renal Physiol (2007) ncbi
not indicated
  • WB; human
Invitrogen anti-E-cadherin antibody was used to perform western blot and immunohistochemistry assays in order to investigate the molecular regulation mechanisms of Smad4 in the process of normal pancreas development and pancreatic ductal adenocarcinomas (PDAC) growth.Adv Drug Deliv Rev (2006) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:100; tbl 7
In order to study the morphological and immunophenotypic features of breast carcinomas with basal and myoepithelial differentiation, Invitrogen E-cadherin antibody (Zymed Laboratories, clone ZHECD-1) was used in immunohistochemistry on human samples at 1:100 (tbl 7). J Pathol (2006) ncbi
not indicated
  • IC; human
Lab Vision anti-Cdh1 antibody was used in immunocytochemistry to study the role of anillin during late cytokinesisJ Biol Chem (2005) ncbi
not indicated
  • WB; human
  • IHC; human
Zymed E-cadherin antibody was used in western blot and immunohistochemistry to study the role of cadherin and catenins in incisures.J Neurosci (2005) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to evaluate an 80 kDa proteolytic fragment of E-cadherin as a potential biomarker for prostate cancer progression and identify proteases responsible for E-cadherin cleavage, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples. Clin Cancer Res (2003) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to test if suppression of Smad3 expression mediates the key oncogenic properties of TGF-beta in gastric cancer, Invitrogen E-cadherin antibody (Zymed, 13?C1700) was used in western blot on human samples. Oncogene (2004) ncbi
mouse monoclonal (HECD-1)
  • WB; human; 1:10000; fig 3
In order to study how inhibitor of beta-catenin and TCF-4 suppresses beta-catenin function, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:10000 (fig 3). Am J Physiol Cell Physiol (2004) ncbi
mouse monoclonal (SHE78-7)
  • IC; human; 1 ug/ml; fig 4
In order to study how p120-catenin stabilizes epithelial cadherin, Invitrogen E-cadherin antibody (Zymed, SHE78?C7) was used in immunocytochemistry on human samples at 1 ug/ml (fig 4). J Cell Biol (2003) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 2
In order to explore cadherin-cadherin interactions, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 2). Mol Cell Biol (2003) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 4
In order to derive and characterize a Wilms' tumour cell line, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 4). Int J Cancer (2003) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:20; fig 1
In order to study expression of E- and N-cadherin in mesotheliomas and adenocarcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:20 (fig 1). Hum Pathol (2003) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:50
  • WB; human; 1:50
In order to discuss the role of the E-cadherin-catenin adhesion complex in cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 and in western blot on human samples at 1:50. Mol Pathol (2003) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200; fig 1
In order to examine E-cadherin inactivation in various types of breast cancer, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Mod Pathol (2003) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; fig 1
In order to test if E-cadherin loss alters the APC/beta-catenin pathway to permit oncogenic beta-catenin signaling in breast cancer, Invitrogen E-cadherin antibody (Zymed, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Int J Cancer (2003) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:200; tbl 1
In order to report the immunohistochemical and molecular genetic features of the cadherins/catenins complex in thyroid carcinoma, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry on human samples at 1:200 (tbl 1). Histopathology (2003) ncbi
mouse monoclonal (HECD-1)
  • IC; human; fig 3a
  • WB; human; fig 3b
In order to elucidate the mechanism of matrilysin in repair, Invitrogen E-cadherin antibody (Zymed, HECD-1)) was used in immunocytochemistry on human samples (fig 3a) and in western blot on human samples (fig 3b). Am J Pathol (2003) ncbi
mouse monoclonal (4A2C7)
  • IC; mouse; 1:100
In order to test if N-cadherin is required for normal myocyte structure and function, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on mouse samples at 1:100. J Cell Sci (2003) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human
In order to determine the role of MMP-19 in skin cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples. Int J Cancer (2003) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human
In order to examine the relationship between paranuclear E-cadherin distribution and the histopathologic characteristics of gastric adenocarcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples. Am J Clin Pathol (2002) ncbi
mouse monoclonal (HECD-1)
  • IHC; human
In order to report that three fibroadenomasfrom one patient simultaneously gave rise to breast carcinoma in situ, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples. J Clin Pathol (2002) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:1000; fig 6
In order to study the existence of novel routes of tumour spread via open channels of pseudoangiomatous stromal hyperplasia, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 6). Histopathology (2002) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to report that activation of the ET-1/ET(B) pathway downregulates E-cadherin in human melanocytes and melanoma cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples. J Clin Invest (2002) ncbi
mouse monoclonal (4A2C7)
  • IHC; human; tbl 2
In order to discuss and characterize 2 distinct variants of intraepithelial neoplasia, Invitrogen E-cadherin antibody (Zymed Laboratories, clone 4A2C7) was used in immunohistochemistry on human samples (tbl 2). Hum Pathol (2002) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; fig 3
In order to optimize E-cadherin immunostaining in paraffin sections to detect variants of ductal infiltrating breast cancer, Invitrogen E-cadherin antibody (Zymed Labs, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 3). Histopathology (2002) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 4
In order to explore the relationship between anti-apoptotic signaling and N-cadherin, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 4). J Biol Chem (2002) ncbi
mouse monoclonal (HECD-1)
  • Neut; human; fig 6
In order to investigate how Cas phosphorylation and Src kinase activation regulate TGF-beta signal transduction, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in neutralization on human samples (fig 6). J Biol Chem (2002) ncbi
mouse monoclonal (HECD-1)
  • IC; human; 1:100; fig 1
  • WB; human; 1:1000; fig 1
In order to study the regulation of adherens junctions, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunocytochemistry on human samples at 1:100 (fig 1) and in western blot on human samples at 1:1000 (fig 1). Nat Cell Biol (2002) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; mouse; 1:100; fig 2
  • WB; mouse; 1:1000; fig 1
In order to explore the effect of cadherin specificity on cardiac structure and function, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:1000 (fig 1). J Cell Sci (2002) ncbi
mouse monoclonal (HECD-1)
  • Neut; human
In order to study beta1-integrin during cell movement, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in neutralization on human samples. Cancer Res (2002) ncbi
mouse monoclonal (HECD-1)
  • WB; human; 1:5000
In order to investigate the cis sequences and transcription factors that regulate E-cadherin expression in breast cancer cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:5000. Cancer Res (2002) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human
In order to examine epithelial-type cadherin and neural-type cadherin as diagnostic markers of malignant noncarcinomatous neoplasms, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples. Arch Pathol Lab Med (2002) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 2
  • IC; human; fig 4
In order to determine how adhesion systems contribute to enterocyte differentiation, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in western blot on human samples (fig 2) and in immunocytochemistry on human samples (fig 4). J Cell Sci (2002) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 5
In order to investigate immortalized human ovarian surface epithelial, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 5). Clin Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human
In order to report that E-CD expression in human breast cancer has minimal prognostic value, but may serves as a phenotypic marker, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples. Br J Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; fig 3
In order to test if tight junction antigens are present in adult and developing human epidermis, Invitrogen E-cadherin antibody (Zymed, 13?C1700) was used in immunohistochemistry - paraffin section on human samples (fig 3). J Invest Dermatol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-F; human; 1:200
In order to examine the prevalence and nature of E-cadherin alterations in sporadic gastric carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - frozen section on human samples at 1:200. Mod Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:1000
In order to study different genes involved in oncogenesis of colon and rectal cancers and examine their prognostic value, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000. J Pathol (2001) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human; 1:50; fig 4
In order to study lobular carcinoma in situ, Invitrogen E-cadherin antibody (Zymed, clone 4A2 C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4). Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; tbl 1
In order to discuss using expression of cadherins and catenins as prognosis markers for cancer, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (tbl 1). J Mammary Gland Biol Neoplasia (2001) ncbi
mouse monoclonal (4A2C7)
  • IHC-P; human
In order to determine the immunoexpression of deleted in colon cancer, p53, E-cadherin, and beta-catenin in the duodenal mucosa of children with coeliac disease, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples. J Clin Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:800
In order to describe a patient affected by endometrial cancer and treated primarily with leuprolide, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:800. Br J Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; fig 1
In order to determine E-cadherin expression in a broad range of prostate tissue, Invitrogen E-cadherin antibody (Zymed Laboratories, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Hum Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; fig 1
In order to describe the clinicopathological features of papillary thyroid carcinoma, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry on human samples (fig 1). J Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • Neut; human
  • IP; human; fig 3d
  • IHC; human; fig 3f
  • WB; human; fig 2
In order to study lymphovascular invasion in breast cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in neutralization on human samples, in immunoprecipitation on human samples (fig 3d), in immunohistochemistry on human samples (fig 3f), and in western blot on human samples (fig 2). Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200
In order to elucidate the role of MUC1 in breast carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to examine adhesion- versus a beta-catenin signaling-dependent mechanisms of E-cadherin tumor suppressor activity, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples. J Cell Biol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:100
In order to discuss the classification and grading systems for ductal carcinoma in situ of the breast, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:100. Am J Clin Pathol (2001) ncbi
mouse monoclonal (SHE78-7)
  • FC; human
  • WB; human
In order to assess the functional significance of N-cadherin in melanoma cells, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in flow cytometry on human samples and in western blot on human samples. Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:500
In order to study E cadherin expression in lobular carcinoma in situ, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:500. Mol Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:1000; fig 1
In order to identify genetic alterations in lobular carcinoma in situ, Invitrogen E-cadherin antibody (Zymed Laboratories, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1). Hum Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:1000; tbl 3
In order to study genetic alterations in tubular carcinomas of the breast, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:1000 (tbl 3). Hum Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to investigate E-cadherin in prostate cancer samples, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples. Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200
In order to determine E-cadherin expression in in situ and invasive carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200. Am J Clin Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC; human; 1:200
In order to discuss the relationship between the adhesive characteristics of hematopoietic cells and their maturation, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:200. Arch Pathol Lab Med (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; mouse; 1:100
In order to investigate the role of N-cadherin in cardiogenesis, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Development (2001) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human
In order to characterize a human midgut carcinoid tumor after transplantation into nude mice, Invitrogen E-cadherin antibody (zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples. Am J Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to study E-cadherin in hematopoietic tissues, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples. Clin Cancer Res (2000) ncbi
mouse monoclonal (HECD-1)
  • IHC; human
In order to examine stromelysin-2 and other matrix metalloproteinase expression during wound healing, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples. J Invest Dermatol (2000) ncbi
mouse monoclonal (HECD-1)
  • WB; human; fig 2
  • IC; human
In order to investigate how time at confluence affects cultured human retinal pigment epithelium cells, Invitrogen E-cadherin antibody (Zymed Laboratories, clone HECD-1) was used in western blot on human samples (fig 2) and in immunocytochemistry on human samples. Invest Ophthalmol Vis Sci (2000) ncbi
mouse monoclonal (HECD-1)
  • IHC-F; cow
  • IHC; cow
In order to determine the distribution of Na/K ATPase and E-cadherin in retinal pigment epithelium cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - frozen section on cow samples and in immunohistochemistry on cow samples. Invest Ophthalmol Vis Sci (2000) ncbi
mouse monoclonal (SHE78-7)
  • IHC-F; cow
  • IHC; cow
In order to determine the distribution of Na/K ATPase and E-cadherin in retinal pigment epithelium cells, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in immunohistochemistry - frozen section on cow samples and in immunohistochemistry on cow samples. Invest Ophthalmol Vis Sci (2000) ncbi
mouse monoclonal (HECD-1)
  • FC; human
In order to examine the role of E-cadherin in melanoma-keratinocyte interaction, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples. Am J Pathol (2000) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human
In order to examine the role of E-cadherin in melanoma-keratinocyte interaction, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in neutralization on human samples. Am J Pathol (2000) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human
In order to study the Ig-like fold of E-cadherin, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in neutralization on human samples. J Exp Med (2000) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; fig 1
In order to study the cellular origin of bladder carcinosarcoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Eur Urol (2000) ncbi
mouse monoclonal (SHE78-7)
  • WB; human; fig 4
In order to test if truncation of E-cadherin results in epithelial apoptosis during prostate and mammary involution, Invitrogen E-cadherin antibody (Zymed, clone SHE78-7) was used in western blot on human samples (fig 4). J Biol Chem (2000) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human; fig 4
In order to determine if p21 contributes to anchorage-dependent growth control, Invitrogen E-cadherin antibody (Zymed, clone SHE78-7) was used in neutralization on human samples (fig 4). Cancer Res (2000) ncbi
mouse monoclonal (HECD-1)
  • IHC-F; human
In order to validate the use of polymerase chain reaction-amplified full-length cDNA as a substitute for mRNA in nucleic acid array and gene expression analysis, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - frozen section on human samples. Invest Ophthalmol Vis Sci (1999) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human
In order to analyze 40 human lobular breast cancers for loss of heterozygosity and other mutations, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples. Br J Cancer (1999) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human
In order to test if cadherin-cadherin interactions modulate keratinocyte differentiation, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in neutralization on human samples. J Cell Sci (1999) ncbi
mouse monoclonal (HECD-1)
  • IC; human; 1:400
In order to determine the role of tyrosine phosphorylation in regulating intercellular adhesion of intestinal cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 1:400. Biochim Biophys Acta (1999) ncbi
mouse monoclonal (HECD-1)
  • IC; human
In order to test if retinal pigment epithelial express E-cadherin, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples. Invest Ophthalmol Vis Sci (1999) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; fig 3
In order to discuss the role of cadherins in tumor development, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 3). Cancer (1999) ncbi
mouse monoclonal (HECD-1)
  • IHC-F; human; fig 1
In order to determine the localization of type XIII collagen in normal human skin and cultured keratinocytes, Invitrogen E-cadherin antibody (Zymed, 13?C1700) was used in immunohistochemistry - frozen section on human samples (fig 1). J Invest Dermatol (1999) ncbi
mouse monoclonal (HECD-1)
  • IC; human; fig 3
  • IP; human; fig 2
  • WB; human; fig 2
In order to report the gain of N-cadherin and loss of E-cadherin by invasive prostate carcinoma cell lines, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 3), in immunoprecipitation on human samples (fig 2), and in western blot on human samples (fig 2). Am J Pathol (1999) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:800; fig 1
In order to assess the loss of E-cadherin expression in early gastric carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 1). Histopathology (1999) ncbi
mouse monoclonal (HECD-1)
  • IC; human
In order to study the relationship of cadherins E, N and P to ovarian surface epithelium morphology, growth patterns and differentiation, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples. Int J Cancer (1999) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human
In order to assess the role of E-cadherin and retinoblastoma tumor suppressor in cell survival and programed cell death, Invitrogen E-cadherin antibody (Zymed, 13-5700) was used in neutralization on human samples. J Biol Chem (1999) ncbi
mouse monoclonal (HECD-1)
  • WB; human
In order to assess the role of E-cadherin and retinoblastoma tumor suppressor in cell survival and programed cell death, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples. J Biol Chem (1999) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 1:200; fig 2
In order to characterize the localization and function of the EDA protein, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Exp Dermatol (1998) ncbi
mouse monoclonal (SHE78-7)
  • Neut; mouse
In order to study the growth suppressor activity of E-cadherin, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in neutralization on mouse samples. J Cell Biol (1998) ncbi
mouse monoclonal (SHE78-7)
  • Neut; human
In order to report that cadherin-mediated intercellular adhesions promote anchorage-independent growth and suppresses apoptosis, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in neutralization on human samples. J Biol Chem (1998) ncbi
mouse monoclonal (HECD-1)
  • IC; human
In order to propose that ubiquitin-conjugating E2 enzyme variant proteins control differentiation by altering cell cycle distribution, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples. Mol Cell Biol (1998) ncbi
mouse monoclonal (HECD-1)
  • FC; human; 1:1000; fig 2
In order to determine the effect of UV radiation on Langerhans' cells co-stimulatory molecules in vivo, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples at 1:1000 (fig 2). Eur J Immunol (1997) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human
In order to identify markers to determine lymph node metastases in patients with gastric cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples. Br J Cancer (1996) ncbi
mouse monoclonal (HECD-1)
  • IHC-P; human; 5 ug/ml
In order to assess E-cadherin expression in paraffin-embedded whole prostates and metastatic prostate cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 5 ug/ml. Am J Pathol (1996) ncbi
mouse monoclonal (HECD-1)
  • FC; human
In order to determine the expression of cellular adhesion molecules on different human prostate tumor cell lines, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples. Prostate (1995) ncbi
Santa Cruz Biotechnology
rabbit polyclonal (H-108)
  • IHC; mouse; 1:250
In order to describe a novel type of kidney cell, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-7870) was used in immunohistochemistry on mouse samples at 1:250. Cell Tissue Res (2016) ncbi
mouse monoclonal (G-10)
  • WB; mouse
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on mouse samples. Cell Physiol Biochem (2015) ncbi
mouse monoclonal (G-10)
  • WB; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-8426) was used in western blot on human samples. Am J Physiol Lung Cell Mol Physiol (2015) ncbi
rabbit polyclonal (H-108)
  • WB; human; 1:200
In order to test if urinary fluid shear stress alters the epithelial characteristics of the renal tubule, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, Sc-7870) was used in western blot on human samples at 1:200. PLoS ONE (2015) ncbi
rabbit polyclonal (H-108)
  • WB; rat; 1:1000
In order to investigate the role of zinc in the epithelial to mesenchymal transition, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in western blot on rat samples at 1:1000. Int J Mol Med (2015) ncbi
rabbit polyclonal (H-108)
  • WB; human; 1:1000
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in western blot on human samples at 1:1000. Mol Med Rep (2015) ncbi
rat monoclonal (DECMA-1)
  • WB; human; 1:500
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotech, sc-59778) was used in western blot on human samples at 1:500. Biochem Biophys Res Commun (2015) ncbi
rabbit polyclonal (H-108)
  • IC; human; 1:50
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in immunocytochemistry on human samples at 1:50. Biomaterials (2015) ncbi
rabbit polyclonal (H-108)
  • IC; human; 1:150
  • WB; human; 1:100
In order to assess the role of Shh signaling in bladder cancer, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-7870) was used in immunocytochemistry on human samples at 1:150 and in western blot on human samples at 1:100. Mol Carcinog (2015) ncbi
rabbit polyclonal (H-108)
  • IHC-P; human
  • WB; human; fig 5
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-7870) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples (fig 5). Mol Oncol (2015) ncbi
rabbit polyclonal (H-108)
  • IHC-P; mouse
  • IC; mouse
In order to examine the role of the mammalian acid sphingomyelinase/ceramide system in the development of lung edema caused by S. aureus, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology Inc., sc-7870) was used in immunohistochemistry - paraffin section on mouse samples and in immunocytochemistry on mouse samples. J Mol Med (Berl) (2015) ncbi
rat monoclonal (DECMA-1)
  • IHC-P; mouse; 1:1000
In order to evaluate an in vitro murine-derived fundic organoids for the study of gastric physiology, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc59778) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000. J Physiol (2015) ncbi
goat polyclonal (S-17)
  • IHC-P; mouse; 10 ug/ml
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-31020) was used in immunohistochemistry - paraffin section on mouse samples at 10 ug/ml. Nat Commun (2015) ncbi
rabbit polyclonal (H-108)
  • WB; human; 1:1000
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in western blot on human samples at 1:1000. Mol Cells (2014) ncbi
mouse monoclonal (G-10)
  • IC; rabbit; 5 ug/ml
In order to create an in vitro primary lung co-culture platform derived from New Zealand white rabbits, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-8426) was used in immunocytochemistry on rabbit samples at 5 ug/ml. In Vitro Cell Dev Biol Anim (2015) ncbi
rabbit polyclonal (H-108)
  • WB; mouse
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, SC-7870) was used in western blot on mouse samples. Nucl Recept Signal (2014) ncbi
rat monoclonal (DECMA-1)
  • IHC-F; mouse; 1:100
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-59778) was used in immunohistochemistry - frozen section on mouse samples at 1:100. Cell Res (2014) ncbi
rabbit polyclonal (H-108)
  • IHC-P; human; 1:100
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, H-108) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Pathol (2015) ncbi
mouse monoclonal (1.B.54)
  • WB; human; 1:100
In order to determine the role and function of NDRG1 in oral squamous cell carcinoma, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, 1.B.54) was used in western blot on human samples at 1:100. Cancer Lett (2014) ncbi
rabbit polyclonal (H-108)
  • WB; human; 1:200
  • IC; human; 1:250
In order to identify the role of E- cadherin relating to epithelial cell tumors, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, SC7870) was used in western blot on human samples at 1:200 and in immunocytochemistry on human samples at 1:250. BMC Cancer (2014) ncbi
rabbit polyclonal (H-108)
  • IC; cow
In order to investigate the effect of 17 beta-estradiol and progesterone on autophagy during acini formation, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in immunocytochemistry on cow samples. Biomed Res Int (2014) ncbi
rabbit polyclonal (H-108)
  • WB; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in western blot on human samples. Int J Oncol (2014) ncbi
mouse monoclonal (2Q663)
  • IC; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-71008) was used in immunocytochemistry on human samples. Biol Reprod (2014) ncbi
mouse monoclonal (67A4)
  • IC; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, SC-21791) was used in immunocytochemistry on human samples. Mol Biol Cell (2014) ncbi
rabbit polyclonal (H-108)
  • WB; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in western blot on human samples. Oncogenesis (2014) ncbi
rabbit polyclonal (H-108)
  • IC; human; 1:100
  • WB; human; 1:500
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-7870) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples at 1:500. Stem Cell Rev (2014) ncbi
rabbit polyclonal (H-108)
  • WB; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz biotechnology, sc-7870) was used in western blot on human samples. PLoS ONE (2013) ncbi
rabbit polyclonal (H-108)
  • IHC; human; 1:150
  • WB; human; 1:500
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, SC-7870) was used in immunohistochemistry on human samples at 1:150 and in western blot on human samples at 1:500. FASEB J (2014) ncbi
rabbit polyclonal (H-108)
  • IC; human
  • WB; human; 1:1000
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in immunocytochemistry on human samples and in western blot on human samples at 1:1000. Breast Cancer Res Treat (2013) ncbi
mouse monoclonal (67A4)
  • IC; human; 1:100
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-21791) was used in immunocytochemistry on human samples at 1:100. Mol Carcinog (2014) ncbi
rabbit polyclonal (H-108)
  • IC; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-7870) was used in immunocytochemistry on human samples. PLoS ONE (2013) ncbi
rabbit polyclonal (H-108)
  • IP; human; fig 2
In order to study targeting sEcad for treatment of breast cancer, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, H108) was used in immunoprecipitation on human samples (fig 2). Mol Carcinog (2014) ncbi
rabbit polyclonal (H-108)
  • IHC-P; mouse
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc7870) was used in immunohistochemistry - paraffin section on mouse samples. Exp Toxicol Pathol (2013) ncbi
mouse monoclonal (2Q663)
  • IC; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-71008) was used in immunocytochemistry on human samples. Cell Death Dis (2013) ncbi
rabbit polyclonal (H-108)
  • IHC-P; mouse; 1:300
In order to study the use of laser-assisted bioprinting to produce tissue engineered skin substitutes capable of forming skin-like structures, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, SC 7870) was used in immunohistochemistry - paraffin section on mouse samples at 1:300. PLoS ONE (2013) ncbi
mouse monoclonal (G-10)
  • WB; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, SC-8426) was used in western blot on human samples. PLoS ONE (2013) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-E-cadherin antibody was used in western blotting to investigate the function of UPK1A in esophageal squamous cell carcinoma.Cancer Res (2010) ncbi
not indicated
  • IC; human
Santa Cruz Biotechnology mouse anti-E-cadherin antibody (1:100) was used in immunocytochemistry in order to study the CHD1L-ARHGEF9-Cdc42-EMT pathway involved in hepatocellular carcinoma (HCC) progression and metastasis.J Clin Invest (2010) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology Inc anti-E-cadherin antibody was used for western blot in order to investigate the role of TGFB1 in the regulation of Mdm2 expression and late-stage breast cancer metastasis.J Clin Invest (2010) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-E-cadherin antibody was used to detect E-cadherin in western blot in order to reveal the role of Id2 in increasing invasion potential of MCF-7 and SKOV-3 cells.BMC Cancer (2009) ncbi
not indicated
  • WB; human
  • IC; human
Santa Cruz Biotechnology polyclonal anti-E-cadherin antibody was used to carry out western blot analysis and immunofluorescence assays in order to investigate the role of PIP5K1alpha in extracellular calcium induced generation of the second messengers IP3 and keratinocyte differentiation.Mol Biol Cell (2009) ncbi
not indicated
  • IP; human
Santa Cruz Biotechnology E-cadherin antibody was used in immunoprecipitation to show that Rab4A associates with adherens junction signaling proteins.J Androl (2007) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology E-cadherin antibody was used in western blot to demonstrate that combination of Ad-mda7 with Herceptin may be a novel therapy for breast cancer.Cancer Gene Ther (2006) ncbi
not indicated
  • IHC; human
  • IC; human
SCBT E-cadherin antibody was used in immunohistochemistry and immunocytochemistry to investigate the expression of Catenin and c-myc in chronic wounds.Am J Pathol (2005) ncbi
not indicated
  • WB; human
  • IP; human
  • IC; human
SCBT anti-E-cadherin ectodomain antibody (H108) was used in western blot, immunocytochemistry, and immunoprecipitationto study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10Proc Natl Acad Sci U S A (2005) ncbi
Abcam
rat monoclonal (DECMA-1)
  • IC; cow; 1:100
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunocytochemistry on cow samples at 1:100. Anim Reprod Sci (2015) ncbi
rabbit polyclonal
  • IHC-P; mouse; 1:100
In order to investigate the role of follicle-stimulating hormone in intercellular communication, Abcam E-cadherin antibody (Abcam, Ab15148) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Biol Reprod (2015) ncbi
rabbit monoclonal (EP700Y)
  • IHC; human
  • WB; human
In order to investigate the epithelial homeostasis during oral submucous fibrosis progression to cancer, Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry on human samples and in western blot on human samples. J Clin Pathol (2015) ncbi
rabbit monoclonal (EP700Y)
  • IC; human; 1:100
Abcam E-cadherin antibody (Abcam, AB40772) was used in immunocytochemistry on human samples at 1:100. Cell Mol Bioeng (2015) ncbi
mouse monoclonal (HECD-1)
  • IC; human
Abcam E-cadherin antibody (Abcam, clone HECD-1) was used in immunocytochemistry on human samples. Cancer Res (2015) ncbi
rabbit polyclonal
  • WB; mouse; 1:200
In order to study the role of Musashi-1 in blood-testis barrier structure during spermatogenesis, Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on mouse samples at 1:200. Mol Biol Cell (2015) ncbi
rabbit monoclonal (EP700Y)
  • IC; human
In order to study the mechanism for the metastasis of ErbB2-positive breast cancer cells, Abcam E-cadherin antibody (AbCam, ab40772) was used in immunocytochemistry on human samples. J Biol Chem (2015) ncbi
mouse monoclonal (HECD-1)
  • IC; human; 1:100
In order to investigate the role of Zbed3 in malignant phenotype of lung cancer, Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:100. Mol Carcinog (2015) ncbi
rabbit polyclonal
  • IC; human
  • WB; mouse
Abcam E-cadherin antibody (Abcam, ab6529) was used in immunocytochemistry on human samples and in western blot on mouse samples. J Neurosci (2014) ncbi
mouse monoclonal (HECD-1)
  • IC; human; 1:50
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:50. PLoS ONE (2014) ncbi
rabbit polyclonal
  • IC; human
Abcam E-cadherin antibody (Abcam, ab15148) was used in immunocytochemistry on human samples. Mol Cell Endocrinol (2014) ncbi
rabbit polyclonal
  • IC; human; 1:500
Abcam E-cadherin antibody (Abcam, ab-6529) was used in immunocytochemistry on human samples at 1:500. J Cell Physiol (2014) ncbi
rabbit polyclonal
  • WB; human
Abcam E-cadherin antibody (Abcam, Ab16505) was used in western blot on human samples. J Hepatol (2014) ncbi
mouse monoclonal (HECD-1)
  • WB; human
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples. Int J Oncol (2014) ncbi
rabbit monoclonal (EP700Y)
  • IHC; human
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry on human samples. Diagn Pathol (2013) ncbi
rabbit monoclonal (EP700Y)
  • IHC-P; human
  • IC; human
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry - paraffin section on human samples and in immunocytochemistry on human samples. Breast Cancer Res (2013) ncbi
rabbit polyclonal
  • IHC-P; human; 1:200
  • WB; human; 1:500
Abcam E-cadherin antibody (Abcam, ab15148) was used in immunohistochemistry - paraffin section on human samples at 1:200 and in western blot on human samples at 1:500. PLoS ONE (2013) ncbi
mouse monoclonal (HECD-1)
  • IC; human
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples. Fertil Steril (2013) ncbi
mouse monoclonal (HECD-1)
  • FC; human; 1:400
  • IC; human; 1:400
  • WB; human
Abcam E-cadherin antibody (Abcam, HECD-1) was used in flow cytometry on human samples at 1:400, in immunocytochemistry on human samples at 1:400, and in western blot on human samples. Oncogene (2014) ncbi
rat monoclonal (DECMA-1) Abcam anti-human E-cadherin antibody was used to perform cell culture in order to investigate the role of PVRL4 in tumor progression.elife (2013) ncbi
mouse monoclonal (M168)
  • WB; mouse; 1:1000
In order to study the ability of adenosine A2A receptor activation to inhibit epithelial-mesenchymal transition and the development of renal interstitial fibrosis in a murine model, Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on mouse samples at 1:1000. PLoS ONE (2013) ncbi
rabbit polyclonal
  • IC; human
Abcam E-cadherin antibody (Abcam, ab16505) was used in immunocytochemistry on human samples. Cell Cycle (2013) ncbi
rabbit polyclonal
  • IHC-P; mouse; 1:200
Abcam E-cadherin antibody (Abcam, ab15148) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. BMC Biol (2013) ncbi
rabbit polyclonal
  • WB; human
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples. Asian Pac J Cancer Prev (2012) ncbi
not indicated
  • WB; human
  • IHC; human
Abcam Cadherin antibody was used for western blot and immunohistochemistry in order to show that DJ-1 can modulate the AKT pathway.Proc Natl Acad Sci U S A (2010) ncbi
not indicated
  • WB; human
Abcam Cdh1 antibody was used in western blot to investigate the regulation of Cdc6 protein stability by p53.Mol Cell Biol (2005) ncbi
EMD Millipore
rat monoclonal (Decma-1)
  • WB; human
EMD Millipore E-cadherin antibody (Millipore, MABT26) was used in western blot on human samples. Mol Carcinog (2015) ncbi
mouse monoclonal (67A4)
  • Neut; human
EMD Millipore E-cadherin antibody (Merck Millipore, MAB3199Z) was used in neutralization on human samples. Biomaterials (2015) ncbi
rabbit monoclonal (EP700Y)
  • IHC-P; human; 1:25
EMD Millipore E-cadherin antibody (Millipore, EP700Y) was used in immunohistochemistry - paraffin section on human samples at 1:25. Oncotarget (2014) ncbi
mouse monoclonal (67A4)
  • WB; human
EMD Millipore E-cadherin antibody (AbcMillipore, MAB3199) was used in western blot on human samples. Cancer Res (2013) ncbi
not indicated
  • WB; human
  • IHC; human
Chemicon anti-E-cadherin antibody was used in western blot and immunohistochemistry to study the effect of Lipocalin 2 on breast cancer progression.Proc Natl Acad Sci U S A (2009) ncbi
R and D Systems
mouse monoclonal (180224)
  • FC; human
R and D Systems E-cadherin antibody (R&D Systems Europe Ltd, FAB18381P) was used in flow cytometry on human samples. Neoplasia (2015) ncbi
goat polyclonal
  • IC; human
R and D Systems E-cadherin antibody (R&D Systems, AF648) was used in immunocytochemistry on human samples. Dalton Trans (2015) ncbi
goat polyclonal
  • IC; human; 1:100
In order to develop and assess using a human cell line to generate glycosylation proteins, R and D Systems E-cadherin antibody (R&D Systems, AF648) was used in immunocytochemistry on human samples at 1:100. J Biotechnol (2014) ncbi
not indicated
  • ELISA; human
R & D Systems biotinylated anti-E-cadherin monoclonal antibody (clone 841487) was used in ELISA to study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10Proc Natl Acad Sci U S A (2005) ncbi
BioLegend
mouse monoclonal (67A4)
  • FC; human
  • IC; human
In order to use a multi-omics strategy to elucidate the cellular programs altered by Staphylococcus aureus alpha-toxin, BioLegend E-cadherin antibody (BioLegend, 324106) was used in flow cytometry on human samples and in immunocytochemistry on human samples. PLoS ONE (2015) ncbi
mouse monoclonal (67A4)
  • FC; human
BioLegend E-cadherin antibody (Biolegend, 67A4) was used in flow cytometry on human samples. Immunology (2015) ncbi
mouse monoclonal (67A4)
  • FC; human
BioLegend E-cadherin antibody (BioLegend, 67A4) was used in flow cytometry on human samples. Cell Death Dis (2014) ncbi
Enzo Life Sciences
mouse monoclonal (SHE78-7)
  • WB (knockdown); human; fig 7c
  • IC; human; fig 7a
  • block/activate; human; 1 ug/ml; fig 7d
Enzo Life Sciences E-cadherin antibody (Enzo, SHE78-7) was used in western blot (knockdown) on human samples (fig 7c), in immunocytochemistry on human samples (fig 7a), and in blocking or activating experiments on human samples at 1 ug/ml (fig 7d). PLoS ONE (2015) ncbi
mouse monoclonal (SHE78-7)
  • WB; human; 1:1000
  • WB; hamsters; 1:1000
  • IC; human; 1:100
  • IC; hamsters; 1:100
Enzo Life Sciences E-cadherin antibody (Enzo Life Sciences, SHE78-7) was used in western blot on human samples at 1:1000 and on hamsters samples at 1:1000 and in immunocytochemistry on human samples at 1:100 and on hamsters samples at 1:100. Eur J Hum Genet (2014) ncbi
mouse monoclonal (HECD-1)
  • IC; human
Enzo Life Sciences E-cadherin antibody (Enzo Life Sciences, ALX-804-201-C100) was used in immunocytochemistry on human samples. Exp Cell Res (2013) ncbi
AbD Serotec (Bio-Rad)
mouse monoclonal (6F9)
  • IC; human; 1:100
AbD Serotec (Bio-Rad) E-cadherin antibody (AbD Serotec, MCA1482) was used in immunocytochemistry on human samples at 1:100. Mol Pharm (2014) ncbi
Epitomics
rabbit monoclonal
  • WB; human
Epitomics E-cadherin antibody (Epitomics, 5409-1) was used in western blot on human samples. PLoS Genet (2014) ncbi
US Biological
not indicated
  • IHC; human
Usbiological polyclonal rabbit anti-human E-cadherin antibody was used in immunohistochemistry to study the effect of absence of TG2 on the development of interstitial fibrosis induced by UUO, using mice lacking the expression of TG2.Am J Pathol (2008) ncbi
BD Biosciences
mouse monoclonal (36/E-Cadherin)
  • IHC; mouse
In order to determine the functions of EHD1, BD Biosciences E-cadherin antibody (BD-Transduction laboratories, 610181) was used in immunohistochemistry on mouse samples. Dev Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1:300
In order to evaluate the kidney organoids from human iPS cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:300. Nature (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; mouse; 1:500
In order to study the effects of Abeta on the functionality of the blood-CSF barrier, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry on mouse samples at 1:500. J Neurosci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:1000
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples at 1:1000. PLoS Med (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; tbl 2
BD Biosciences E-cadherin antibody (BD Bioscience, 612130) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human
In order to assess the involvement of lysophosphatidic acid in epithelial ovarian carcinoma, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 36/E-cadherin) was used in immunocytochemistry on human samples. J Biol Chem (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:200
In order to study kidney development in Robo2 mouse mutants, BD Biosciences E-cadherin antibody (Becton Dickinson, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Dev Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; fig 4
In order to determine the contributions of Fat1 and Fat4 in eye development, BD Biosciences E-cadherin antibody (Transduction Laboratories, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Invest Ophthalmol Vis Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:5000
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in western blot on human samples at 1:5000. Int J Cancer (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
In order to study the role of p120 phosphorylation in tumor transformation, BD Biosciences E-cadherin antibody (BD Pharmingen, 610182) was used in western blot on human samples. PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1:100; fig 4
In order to describe the proxHCR method for the detection of protein interactions and posttranslational modifications in microscopy and flow cytometry, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1:100 (fig 4). Nat Commun (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:200
In order to investigate the role of transcription factors SOX4 and SOX9 during the development of bile ducts, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Dev Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; mouse; 1:100
In order to study mitochondrial dynamics and morphology in myelinating Schwann cells in living mice, BD Biosciences E-cadherin antibody (BD biosciences, 610181) was used in immunohistochemistry on mouse samples at 1:100. Mitochondrion (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse
In order to study the role of heparan sulfate in corneal epithelial homeostasis and wound healing, BD Biosciences E-cadherin antibody (BD Transduction lab, 610181) was used in immunohistochemistry - paraffin section on mouse samples. Invest Ophthalmol Vis Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; mouse; 1:50
BD Biosciences E-cadherin antibody (BD Biosciences Pharmingen, BD 610182) was used in immunocytochemistry on mouse samples at 1:50. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; cow
  • WB; cow
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on cow samples and in western blot on cow samples. Int J Mol Med (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; fig 3
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
In order to study the relationship between nuclear LASP-1 and the epigenetic machinery in breast cancer, BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples. Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; human
  • WB; human; 1:10000
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples at 1:10000. BMC Cancer (2015) ncbi
not indicated
  • IHC; human
Anti-E-cadherin antibody was used in immunohistochemistry, in order to study the role of Huntingtin in apical polarity during the morphogenesis of the mouse mammary epitheliumPLoS Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
In order to investigate flotillin-1-mediated regulation of insulin-like growth factor-1 signaling, BD Biosciences E-cadherin antibody (BD, 610182) was used in western blot on human samples. J Cell Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; fig 4d
In order to study how pre-transformation MTH1 levels in immortalized cells influence HRASV12-induced oncogenic transformation, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples (fig 4d). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
In order to investigate the role of Snail in the cell cycle regulation and epithelial-mesenchymal transition, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in western blot on human samples. FEBS Lett (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; fig 1
In order to investigate the effects of nicotinamide adenine dinucleotide phosphate reduced oxidase 4 in liver tissues from patients with NASH and mice with steatohepatitis, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples (fig 1). Gastroenterology (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • WB; human
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in western blot on human samples. Lab Invest (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; human; 1:100
In order to develop a screening strategy to rationally select novel and relevant candidate genes to target therapeutically, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • WB; mouse
In order to investigate the deficiency of intestine and microbiome in an amyotrophic lateral sclerosis mouse model, BD Biosciences E-cadherin antibody (BD, 610405) was used in western blot on mouse samples. Physiol Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; pig
In order to describe a clinical scale bioreactor that maintains functional porcine and human lungs, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on pig samples. Biomaterials (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; human; fig 1
In order to elucidate the contributions of cell-cell adhesion proteins to intercellular force and epithelial tissue dynamics, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry on human samples (fig 1). Nat Cell Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
In order to identify genetic alterations and corresponding stable phenotypes that develop in cancer cells following cyclic hypoxia, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples. PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; mouse; 1:200
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on mouse samples at 1:200. PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; human; 1:200
In order to investigate using liver-tumor organoids for in vitro modeling of liver metastasis, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples at 1:200. Ann Biomed Eng (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:1000; fig s4
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 1:1000 (fig s4). Cell (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; rat; 1:200
BD Biosciences E-cadherin antibody (BD Transduction, 36/E-cadherin) was used in immunohistochemistry on rat samples at 1:200. Exp Mol Pathol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:100
  • WB; human
  • IP; human
BD Biosciences E-cadherin antibody (BD Biosciences Dickinson, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100, in western blot on human samples, and in immunoprecipitation on human samples. PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; human; 1:100
In order to determine the prognostic role of the Wnt-signaling antagonist SFRP1 in bladder cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on human samples at 1:100. J Cancer Res Clin Oncol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; fig 5
In order to show that fatty acylated cav-2 is a IR tyrosine kinase substrate during insulin signaling, BD Biosciences E-cadherin antibody (BD, 610182) was used in western blot on human samples (fig 5). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; human
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in immunohistochemistry on human samples. J Invest Dermatol (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • WB; mouse
BD Biosciences E-cadherin antibody (BD Bioscience, 34/E-Cadherin) was used in western blot on mouse samples. Neoplasia (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; rat; 125 ng/ml
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in western blot on rat samples at 125 ng/ml. Endocrinology (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1:50
In order to assess the effects of different cell culturing conditions on the Calu-3 epithelial cell model, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on human samples at 1:50. Eur J Pharm Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:200
In order to examine the role of tropomyosin isoforms in actomyosin biogenesis, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Cytoskeleton (Hoboken) (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human
BD Biosciences E-cadherin antibody (BD Transduction Lab, 610181) was used in immunocytochemistry on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:4000
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples at 1:4000. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-F; mouse
BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-cadherin) was used in immunohistochemistry - frozen section on mouse samples. J Immunol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:1000
  • IC; human; 1:1000
In order to study how DLC2 regulates cell junction maintenance and planar spindle positioning, BD Biosciences E-cadherin antibody (BD, 610182) was used in western blot on human samples at 1:1000 and in immunocytochemistry on human samples at 1:1000. Nat Commun (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
  • IC; human
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples and in immunocytochemistry on human samples. Eur J Pharm Biopharm (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; mouse
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on mouse samples. Oncogene (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:500
BD Biosciences E-cadherin antibody (BD Bioscience, 610 182) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Endocrinology (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:200
BD Biosciences E-cadherin antibody (BD Bioscience, 612 131) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Endocrinology (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; mouse
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in immunocytochemistry on mouse samples. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1 ug/ml
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1 ug/ml. J Lab Autom (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1:200
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:200. Mol Hum Reprod (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; zebrafish; 1:200; fig 4
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on zebrafish samples at 1:200 (fig 4). Nat Commun (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:250
In order to determine the role of Tbx3 in different cell types present in the adult mammary gland, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:250. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:200 or 1:1000
  • IC; human; 1:200 or 1:1000
BD Biosciences E-cadherin antibody (BD, BDB610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 or 1:1000 and in immunocytochemistry on human samples at 1:200 or 1:1000. Cell Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:1000
  • IC; human; 1:200
In order to study the effect of epithelial cadherin expression on the induction of entosis, BD Biosciences E-cadherin antibody (BD Biosciences, BD610181) was used in western blot on human samples at 1:1000 and in immunocytochemistry on human samples at 1:200. Cell Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:250
In order to investigate how serotonin regulates calcium during lactation, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:250. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse
BD Biosciences E-cadherin antibody (BD BioSciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples. Cancer Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; mouse; 1:200
In order to investigate mechanisms by which organs coordinate their size and shape, BD Biosciences E-cadherin antibody (Becton Dickinson, 610182) was used in immunohistochemistry on mouse samples at 1:200. Dev Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human
In order to study the mechanism of the activation of focal adhesion protein vinculin by mechanical stress, BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunocytochemistry on human samples. Cancer Res (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • WB; human
BD Biosciences E-cadherin antibody (BD, 610405) was used in western blot on human samples. J Exp Clin Cancer Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • FC; human; 1:100
In order to evaluate the osteogenic capacity of bone marrow mesenchymal stream cells and gingiva-derived mesenchymal stromal cells, BD Biosciences E-cadherin antibody (BD, 612131) was used in flow cytometry on human samples at 1:100. Biomed Mater (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human
In order to study using RPMI 2650 cells to create an in vitro model of the nasal mucosa, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on human samples. Pharm Res (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; human; 1:100
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Biol Chem (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:1000
  • IC; human; 1:300
In order to study the effect of radiation on the progeny of colorectal cancer cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 1:1000 and in immunocytochemistry on human samples at 1:300. J Cell Biochem (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
In order to investigate the localization of POF1B in desmosomes and its role in human intestinal and keratinocyte cell lines, BD Biosciences E-cadherin antibody (Sigma Aldrich, 610181) was used in western blot on human samples. J Invest Dermatol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; rat
In order to examine the function of R1N1 in regards to Listeria monocytogenes infection, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunocytochemistry on rat samples. Traffic (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 0.25 ug/ml
In order to study ezrin, Cx43 and PKA in cell fusion in cytotrophoblasts, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 0.25 ug/ml. J Cell Sci (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; human; 1:200
In order to study the role of BMP in mammary cancer, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry - paraffin section on human samples at 1:200. Oncogene (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; fig 5
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples (fig 5). Cell (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; dog; 1:400
In order to test if PAR2 activation affects the structure and function of tight junctions in epithelial cells, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunocytochemistry on dog samples at 1:400. J Vet Med Sci (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1:200
In order to investigate the effect of glycosylation on tumor cell adhesion and invasion and its mechanism, BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunocytochemistry on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • WB; human; 1:1000
BD Biosciences E-cadherin antibody (BD, 610404) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; mouse
  • IHC; mouse
In order to study the effect of ankyrin-G on neurogenesis and Wnt signaling and its mechanism, BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in western blot on mouse samples and in immunohistochemistry on mouse samples. Mol Psychiatry (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples. Int J Oncol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; dog
In order to compare two treatment regiments for idiopathic inflammatory bowel disease, BD Biosciences E-cadherin antibody (BD, 36) was used in immunohistochemistry on dog samples. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; mouse; 1:200
In order to study the regulation of autophagosome biogenesis by connexins, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on mouse samples at 1:200. Nat Cell Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:1000
In order to study the ability of miRNA-100 to promote epithelial-to-mesenchymal transition but also to inhibit mammary tumor cell invasiveness and tumorogenesis, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in western blot on human samples at 1:1000. PLoS Genet (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human
In order to determine the role of desmoglein 2 in melanoma cells, BD Biosciences E-cadherin antibody (BD Biosciences Pharmingen, clone 36) was used in immunocytochemistry on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:100
In order to investigate the role of Mdm2 in the nephrogenic niche, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Dev Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples. Exp Cell Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1:200
In order to study treatment resistance mechanisms in triple-negative breast cancers, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on human samples at 1:200. Cancer Discov (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; 1:200; fig 3
In order to describe a protocol for pluripotent-stem-cell-based renal regeneration, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; human; 1:300
In order to study the clinical significance of aldehyde dehydrogenase 1 expression in the invasive front of nasopharyngeal carcinoma, BD Biosciences E-cadherin antibody (BD, 36/E) was used in immunohistochemistry - paraffin section on human samples at 1:300. Virchows Arch (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples. Oncogene (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-F; pig; 1:200
In order to study the effects on piglet colon tight junction composition of a diet high in fibre and fermentable proteins, BD Biosciences E-cadherin antibody (Becton Dickinson Pharmingen, 560062) was used in immunohistochemistry - frozen section on pig samples at 1:200. Br J Nutr (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; rat
BD Biosciences E-cadherin antibody (BD Transduction Labs, 36) was used in immunohistochemistry on rat samples. Dev Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples. J Biol Chem (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:200
In order to examine the role of chromatin modification in nephrogenesis, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Epigenetics (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; mouse
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on mouse samples. Reproduction (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-P; mouse; 1:250
In order to study the role of cell migration in the mechanism by which overexpression of Cdc42 promotes developing mammary gland hyperbranching, BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:250. Breast Cancer Res (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:5000
BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in western blot on human samples at 1:5000. Mol Carcinog (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • WB; human
BD Biosciences E-cadherin antibody (BD Pharmingen, 610404) was used in western blot on human samples. PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; mouse; 1:200
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples at 1:200. Mol Endocrinol (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC; mouse; 1:500
BD Biosciences E-cadherin antibody (BD Pharmingen, 610181) was used in immunohistochemistry on mouse samples at 1:500. Cancer Res (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in western blot on human samples. Evid Based Complement Alternat Med (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; mouse; 1:1000
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on mouse samples at 1:1000. PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human
  • WB; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples and in western blot on human samples. PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; dog; 1:200
In order to study the role of Kif3a in microtubular dynamics, migration and lumen formation of MDCK cells, BD Biosciences E-cadherin antibody (BD Transduction Lab, 610181) was used in immunocytochemistry on dog samples at 1:200. PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • IHC-F; mouse
  • IHC-P; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - frozen section on mouse samples and in immunohistochemistry - paraffin section on human samples. PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; rat
BD Biosciences E-cadherin antibody (BD Transduction Labs, 36) was used in western blot on rat samples. Invest Ophthalmol Vis Sci (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
In order to study the epigenetic changes caused by transient EBV infection and the tumorigenic significance, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples. Int J Cancer (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; mouse; 1:200
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on mouse samples at 1:200. Development (2012) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human
  • WB; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples and in western blot on human samples. J Biol Chem (2012) ncbi
mouse monoclonal (36/E-Cadherin)
  • IC; human; fig 3
In order to measure the expression of epithelial-to-mesenchymal transition-associated proteins in renal cell carcinoma and compared expression levels with clinical outcome, BD Biosciences E-cadherin antibody (BD Sciences, 610181) was used in immunocytochemistry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human; 1:1000
BD Biosciences E-cadherin antibody (BD Laboratories, 610182) was used in western blot on human samples at 1:1000. Cancer Cell (2011) ncbi
mouse monoclonal (36/E-Cadherin)
  • WB; human
BD Biosciences anti-E-cadherin antibody was used to perform western blot in order to study the role of LMP2A in the nasopharyngeal carcinoma progression.PLoS Pathog (2010) ncbi
not indicated
  • WB; human
  • IP; human
  • IHC; human
BD Biosciences anti-E-cadherin was used to perform western blot, immunoprecipitation, and immunohistochemistry in order to study the roles of RBBP9 as a tumor-associated serine hydrolase to pancreatic neoplasiaProc Natl Acad Sci U S A (2010) ncbi
not indicated
  • WB; human
Transduction Laboratories anti-E-cadherin antibody was used for western blot in order to investigate the role of N-WASP in the regulation of Wnt signaling and hair follicle cycling in mice.J Clin Invest (2010) ncbi
not indicated
  • WB; human
  • IC; human
BD Biosciences anti-E-cadherin antibody was used to carry out western blot and immunostaining assays in order to investigate the role of the T-box transcription factor Brachyury in tumor cells epithelial-mesenchymal transition and and tumor progression.J Clin Invest (2010) ncbi
not indicated
  • IC; human
  • WB; human
Becton Dickinson anti-E-cadherin was used to perform western blot and immunocytochemistry in order to show that MRP protein plays an important role in adherens junction formation and tumorigenesis .PLoS ONE (2009) ncbi
not indicated
  • WB; human
  • IHC; human
BD Biosciences anti-E-cadherin antibody was used to perform western blot and immunohistochemistry in order to study the mechanism of the epithelial-mesenchymal transition in human mammary carcinoma cells induced by Six1 homeoprotein.J Clin Invest (2009) ncbi
not indicated
  • IC; human
BD Biosciences monoclonal anti-E-cadherin antibody was used in immunocytochemistry to study intersection between cadherin-based adherens junctions (AJ) and the Wnt signaling pathwayPLoS ONE (2009) ncbi
not indicated
  • WB; human
BD anti-E-cadherin antibody was used to perform western blot in order to study the role of HMGA2 in maintaining the oncogenic RAS-induced epithelial-mesenchymal transition.Am J Pathol (2009) ncbi
not indicated
  • WB; human
BD transduction laboratories mouse monoclonal anti-E-cadh antibody was used in western blot to analyze the early events that are specifically induced by the apical supply of PPM and to determine the molecular mechanisms of PPM sensing in enterocytes.PLoS ONE (2009) ncbi
not indicated
  • WB; human
BD Biosciences anti-E-cadherin antibody was used to carry out western blot analysis in order to investigate the role for Smurf2 in promoting breast cancer metastasis.Cancer Res (2009) ncbi
not indicated
  • IC; human
BD Biosciences mouse monoclonal E-cadherin antibody was used in immunocytochemistry in order to study the role for FA pathways in the maintenance of differentiation-dependent cell cycle exitOncogene (2009) ncbi
not indicated
  • WB; human
BD Biosciences mouse monoclonal anti-E-cadherin antibody was used to carry out western blot analysis in order to investigate the roles for HMGA2 and Smads in the regulation of SNAIL1 expression during epithelial-mesenchymal transition.J Biol Chem (2008) ncbi
not indicated
  • IC; human
BD Biosciences mouse IgG2a anti-E-cadherin antibody (1:100) was used to perform immunocytochemistry in order to study cadherin-mediated cell-cell contact in early keratinocyte differentiation.J Invest Dermatol (2009) ncbi
not indicated
  • WB; human
BD Bioscience anti-E-cadherin antibody was used for western blot in order to investigate the role of SRF in endothelial cell in the regulation of early vascular developmentBMC Dev Biol (2008) ncbi
not indicated
  • WB; human
BD Biosciences anti-E-cadherin was used to perform western blot in order to investigate the role of the tetraspanin TM4SF5 in contact inhibition and tumorigenesis.J Clin Invest (2008) ncbi
not indicated
  • WB; human
  • IP; human
BD PharMingen E-cadherin antibody was used in western blot and immunoprecipitation to demonstrate that KLRG1 differentially regulates NK cell and T cell functions.Int Immunol (2007) ncbi
not indicated
  • WB; human
BD Transduction Laboratories anti-E-cadherin antibody was used to perform western blot in order to investigate the molecular mechanisms of HGF-induced cell scattering.EMBO J (2006) ncbi
not indicated
  • WB; human
BD Biosciences anti-E-cadherin antibody was used in western blot to report that COX-2-dependent pathways contribute to the modulation of E-cadherin expression in NSCLC.Cancer Res (2006) ncbi
not indicated
  • WB; human
Transduction Laboratories antibody against E-cadherin was used in western blot to detect E-cadherin in human MCF-7 cellsProc Natl Acad Sci U S A (2006) ncbi
not indicated
  • IHC; human
BD Biosciences anti-E-cadherin antibody was used in immunohistochemistry to study the expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.Clin Cancer Res (2006) ncbi
not indicated
  • WB; human
Transduction Laboratories monoclonal anti-E-cadherin antibody was used in human A549 cells and in western blot to study the interaction between the receptor protein-tyrosine phosphatase PTP and IQGAP1.J Biol Chem (2006) ncbi
not indicated
  • WB; human
BD Biosciences mouse anti-E-cadherin was used in western blot to examine E-cadherin expression in normal human keratinocytes (NHKs).J Biol Chem (2006) ncbi
not indicated
  • IC; human
Transduction Laboratories mouse monoclonal anti-human E-cadherin antibody was used in human cells and in immunocytochemistry to study the involvement of transendothelial migration of melanoma cells in N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway.Mol Biol Cell (2005) ncbi
not indicated
  • WB; human
BD monoclonal antibody against the cytoplasmic domain of E-cadherin (C36) was used in western blot, immunocytochemistry, and immunoprecipitationto study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10Proc Natl Acad Sci U S A (2005) ncbi
not indicated
  • WB; human
BD Biosciences anti E-cadherin antibody was used in western blot to demonstrate that beta-catenin signaling is activated in tubular epithelial and interstitial cells after renal injury.J Am Soc Nephrol (2005) ncbi
not indicated
  • IHC; human
BD Biosciences mouse monoclonal anti-E-cadherin antibody was used in immunohistochemistry to study the association of alpha-Methylacyl-CoA racemase protein expression with the degree of differentiation in breast cancer.Cancer Epidemiol Biomarkers Prev (2005) ncbi
not indicated
  • WB; human
BD Transduction Laboratories mouse anti-E-cadherin mAb was used in western blot and immunocytochemistry to study the regulation of E-cadherin endocytosis by nectinJ Biol Chem (2005) ncbi
not indicated
  • WB; human
  • IC; human
BD Biosciences E-cadherin antibody was used in western blot and immunocytochemistry to study the role of Par-3 in epithelial cell polarization in mammals.Nat Cell Biol (2005) ncbi
not indicated
  • WB; human
  • IHC; human
Transduction Laboratories mouse monoclonal anti E-cadherin antibody was used in western blot and immunohistochemistry to study L1 expression in colon cancersJ Cell Biol (2005) ncbi
not indicated
  • WB; human
  • IP; human
BD Transduction Laboratories monoclonal antibody to E-cadherin was used in immunoprecipitation to isolate E-cadherin from human HaCaT cells, and in western blot to detect the amount of E-cadherin in HaCaT cells.J Biol Chem (2005) ncbi
not indicated
  • WB; human
BD Transduction Laboratories mouse monoclonal anti-E-cadherin antibody was used in western blot to study the effect of E-cadherin on fibroblast growth factor receptor 1Mol Biol Cell (2005) ncbi
Cell Signaling Technology
rabbit monoclonal (24E10)
  • WB; human; 1:1000; fig 4
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology , #3195) was used in western blot on human samples at 1:1000 (fig 4). Int J Cancer (2016) ncbi
rabbit monoclonal (24E10)
  • IC; human
In order to study OGR1-mediated, pH-dependent signaling pathways in intestinal epithelial cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples. Am J Physiol Gastrointest Liver Physiol (2015) ncbi
rabbit monoclonal (24E10)
  • WB; human
Cell Signaling Technology E-cadherin antibody (CST, #3195) was used in western blot on human samples. Oncol Rep (2015) ncbi
mouse monoclonal (32A8)
  • IHC-P; human; 1:200
In order to develop a 3D model for studying tumors by co-culturing HT-29 tumor spheroids with CCD-18co fibroblasts, Cell Signaling Technology E-cadherin antibody (Cell signaling, 5296) was used in immunohistochemistry - paraffin section on human samples at 1:200. Exp Cell Res (2015) ncbi
rabbit monoclonal (24E10)
  • IHC-P; mouse; 1:200; fig 6
  • WB; mouse; 1:1000; fig 6
In order to assess the effects of Shenling Baizhu San on colitis-associated colorectal cancer, Cell Signaling Technology E-cadherin antibody (CST, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6) and in western blot on mouse samples at 1:1000 (fig 6). BMC Complement Altern Med (2015) ncbi
rabbit monoclonal (24E10)
  • IC; mouse; 1:400; fig 6
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in immunocytochemistry on mouse samples at 1:400 (fig 6). BMC Dev Biol (2015) ncbi
rabbit monoclonal (24E10)
  • WB; human; 1:500
In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
rabbit monoclonal (24E10)
  • WB; human; 1:1000; fig 4
  • IHC; human; 1:400; fig 4
In order to demonstrate that the p53-R248Q mutant targets the proteasome activator REGgamma to promote endometrial cancer progression, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 4) and in immunohistochemistry on human samples at 1:400 (fig 4). Cancer Lett (2015) ncbi
rabbit monoclonal (24E10)
  • IHC; mouse
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry on mouse samples. PLoS ONE (2015) ncbi
rabbit monoclonal (24E10)
  • WB; human; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 5). Mol Oncol (2015) ncbi
rabbit monoclonal (24E10)
  • WB; human; fig 4
In order to investigate the roles and mechanisms of the RSPO-LGR system in oncogenesis, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4). Oncogene (2015) ncbi
rabbit monoclonal (24E10)
  • FC; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in flow cytometry on human samples. Clin Cancer Res (2015) ncbi
rabbit monoclonal (24E10)
  • IHC; human; 1:100
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in immunohistochemistry on human samples at 1:100. BMC Vet Res (2014) ncbi
rabbit monoclonal (24E10)
  • IC; mouse; 1:200
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on mouse samples at 1:200. J Clin Invest (2014) ncbi
rabbit monoclonal (24E10)
  • IHC; human; 1:400; fig 4
In order to determine the effects of targeting the VEGF and c-met pathways in clear cell renal cell carcinoma models, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples at 1:400 (fig 4). Mol Cancer Ther (2015) ncbi
rabbit monoclonal (24E10)
  • IC; human; fig 4
In order to demonstrate the transcriptional repression of ANXA2 by ERG in prostate epithelial cells and discuss how this interaction relates to prostate cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 4). Mol Cancer Res (2015) ncbi
rabbit monoclonal (24E10)
  • WB; human
  • IC; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples and in immunocytochemistry on human samples. J Biol Chem (2014) ncbi
rabbit monoclonal (24E10)
  • WB; human
Cell Signaling Technology E-cadherin antibody (Cell Signalling Technology, 3195S) was used in western blot on human samples. Cell Prolif (2014) ncbi
rabbit monoclonal (24E10)
  • WB; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples. Cancer Cell (2014) ncbi
rabbit monoclonal (24E10)
  • WB; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling technology, 3195P) was used in western blot on human samples. PLoS ONE (2014) ncbi
rabbit monoclonal (24E10)
  • IHC-P; human; 1:600
  • WB; human; 1:800
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:600 and in western blot on human samples at 1:800. Urol Oncol (2014) ncbi
rabbit monoclonal (24E10)
  • IC; mouse; 1:100
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunocytochemistry on mouse samples at 1:100. Exp Eye Res (2014) ncbi
rabbit monoclonal (24E10)
  • WB; human
Cell Signaling Technology E-cadherin antibody (Cell Signal Technology, 24E10) was used in western blot on human samples. Biochim Biophys Acta (2014) ncbi
rabbit monoclonal (24E10)
  • WB; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples. PLoS ONE (2014) ncbi
rabbit monoclonal (24E10)
  • WB; human
In order to show that uPAR regulates nasopharyngeal carcinoma NPC progression, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples. Cell Cycle (2014) ncbi
rabbit monoclonal (24E10)
  • IHC-P; mouse; 1:500
In order to study the ability of miRNA-100 to promote epithelial-to-mesenchymal transition but also to inhibit mammary tumor cell invasiveness and tumorogenesis, Cell Signaling Technology E-cadherin antibody (Cell signaling Technology, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. PLoS Genet (2014) ncbi
rabbit monoclonal (24E10)
  • WB; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in western blot on human samples. Br J Cancer (2014) ncbi
rabbit monoclonal (24E10)
  • IC; mouse; fig 6h
In order to assess intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunocytochemistry on mouse samples (fig 6h). PLoS ONE (2014) ncbi
mouse monoclonal (32A8)
  • WB; human; fig 5
In order to identify miRNAs that contribute to prostate cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 5296) was used in western blot on human samples (fig 5). Oncogene (2014) ncbi
rabbit monoclonal (24E10)
  • WB; mouse
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on mouse samples. Mol Cancer Ther (2013) ncbi
rabbit monoclonal (24E10)
  • IHC-P; mouse
Cell Signaling Technology E-cadherin antibody (Cell signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples. EMBO Mol Med (2013) ncbi
not indicatedCell Signaling Technology anti-CDH1-Alexa 488 monoclonal antibody was used to perform immunostaining in order to study microtube density and cell-cell adhesionPLoS Biol (2011) ncbi
not indicated
  • WB; human
Cell Signaling anti-E-cadherin antibody (1:1000) was used in western blot in order to study the role of AQP5 in the invasion of human non small cell lung cancerPLoS ONE (2008) ncbi
Dako
mouse monoclonal (NCH-38)
  • IHC-P; human; 1:20
In order to identify master regulators of inflammatory breast cancer, Dako E-cadherin antibody (DAKO, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:20. J Transl Med (2015) ncbi
mouse monoclonal (NCH-38)
  • IHC; human
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples. PLoS ONE (2015) ncbi
mouse monoclonal (NCH-38)
  • IHC; human; 1:30
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry on human samples at 1:30. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (NCH-38)
  • IHC; human; 1:15
In order to describe a new method for immunohistochemistry optimization, Dako E-cadherin antibody (DakoCytomation, M3612) was used in immunohistochemistry on human samples at 1:15. Histopathology (2015) ncbi
mouse monoclonal (NCH-38)
  • IHC-P; human; 1:50
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples at 1:50. APMIS (2015) ncbi
mouse monoclonal (NCH-38)
  • IHC; human; 1:100
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (NCH-38)
  • IHC-P; human; 1:80
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:80. Comp Med (2014) ncbi
mouse monoclonal (NCH-38)
  • IHC; human; fig s1
In order to examine the mechanism of EML4-ALK rearrangement using a novel cell line, Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples (fig s1). J Thorac Oncol (2014) ncbi
mouse monoclonal (NCH-38)
  • IHC-P; sheep; 1:100
Dako E-cadherin antibody (Dako Cytomation, NCH-38) was used in immunohistochemistry - paraffin section on sheep samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (NCH-38)
  • IHC-P; human; ready-to-use
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples at ready-to-use. Ann Diagn Pathol (2014) ncbi
mouse monoclonal (NCH-38)
  • IC; human; 1:50
Dako E-cadherin antibody (Dako, M3612) was used in immunocytochemistry on human samples at 1:50. J Mol Endocrinol (2014) ncbi
mouse monoclonal (NCH-38)
  • IHC-P; human
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples. Int J Gynecol Pathol (2014) ncbi
mouse monoclonal (NCH-38)
  • IHC; human; fig 1
In order to study the ability of Met inhibitors to reverse chemoresistance in small cell lung cancer and the role of epithelial-to-mesenchymal transition, Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples (fig 1). Clin Cancer Res (2014) ncbi
not indicated
  • IHC; human
Dako anti-E-Cadherin(NCH-38) antibody was used to perform immunohistochemistry in order to study the expression of cytokeratin 7 and 19 are related with genomic stability and favorable prognosis in clear cell renal cell cancer.Int J Cancer (2008) ncbi
Sigma-Aldrich
rat monoclonal (DECMA-1)
  • IC; mouse; 1:800; fig 5s
Sigma-Aldrich E-cadherin antibody (Sigma-Aldrich, U3254) was used in immunocytochemistry on mouse samples at 1:800 (fig 5s). Pflugers Arch (2015) ncbi
mouse monoclonal (CH-19)
  • IHC-F; mouse
In order to characterize the electrophysiological and tissue alterations correlated with enhanced arrhythmogenicity in mouse models of renal failure, Sigma-Aldrich E-cadherin antibody (Sigma-Aldrich, C1821) was used in immunohistochemistry - frozen section on mouse samples. Cardiorenal Med (2015) ncbi
mouse monoclonal (CH-19)
  • IHC; mouse; 1:250; fig 2
In order to determine tissue specific functions of DLL1 or DLL4 using transgenic mice, Sigma-Aldrich E-cadherin antibody (Sigma, C1821) was used in immunohistochemistry on mouse samples at 1:250 (fig 2). PLoS Genet (2015) ncbi
mouse monoclonal (CH-19)
  • IHC-F; chicken; 1:100; fig S5
In order to study the role of vertebrate Hox proteins during the partitioning of the developing hindbrain into rhombomeres, Sigma-Aldrich E-cadherin antibody (Sigma, C1821) was used in immunohistochemistry - frozen section on chicken samples at 1:100 (fig S5). Development (2014) ncbi
mouse monoclonal (CH-19)
  • IHC; mouse
In order to identify the substrates for ABCC11 and gamma-glutamyl transferase 1 in the apocrine sweat gland, Sigma-Aldrich E-cadherin antibody (Sigma, C1821) was used in immunohistochemistry on mouse samples. Exp Dermatol (2014) ncbi
rat monoclonal (DECMA-1)
  • WB; human
In order to evaluate the prognostic value of fascin in pancreatic cancer, Sigma-Aldrich E-cadherin antibody (Sigma, DECMA1) was used in western blot on human samples. Gastroenterology (2014) ncbi
rat monoclonal (DECMA-1)
  • IHC; mouse; 1:1000
In order to investigate the role of Snail during progression of epithelial cancer, Sigma-Aldrich E-cadherin antibody (Sigma, U-3254) was used in immunohistochemistry on mouse samples at 1:1000. Cell Death Differ (2014) ncbi
rat monoclonal (DECMA-1)
  • IC; dog
In order to identify the mechanism for the vascular permeability syndrome and respiratory distress in severe dengue, Sigma-Aldrich E-cadherin antibody (Sigma-Aldrich, U3254) was used in immunocytochemistry on dog samples. J Virol (2013) ncbi
rat monoclonal (DECMA-1)
  • IHC-F; mouse
In order to profile the expression pattern of globose basal cells within the olfactory epithelium, Sigma-Aldrich E-cadherin antibody (Sigma, U3254) was used in immunohistochemistry - frozen section on mouse samples. J Comp Neurol (2013) ncbi
mouse monoclonal (CH-19)
  • IC; human; fig 2
In order to measure the expression of epithelial-to-mesenchymal transition-associated proteins in renal cell carcinoma and compared expression levels with clinical outcome, Sigma-Aldrich E-cadherin antibody (Sigma-Aldrich, C1821) was used in immunocytochemistry on human samples (fig 2). PLoS ONE (2012) ncbi
not indicated
  • WB; human
  • IC; human
Sigma anti-E-cadherin antibody was used to carry out western blot analysis and immunofluorescence assays in order to investigate the role for Btbd7 in promoting epithelial tissue remodeling and branching morphogenesis.Science (2010) ncbi
not indicated
  • Neut; human
Sigma-Aldrich anti-DECMA-1 antibody was used to perform blocking experiments in order to study cadherin-mediated cell-cell contact in early keratinocyte differentiation.J Invest Dermatol (2009) ncbi
not indicated
  • Neut; human
Sigma N-terminal E-cadherin antibody DECMA-1 was used in blocking expriments to study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10Proc Natl Acad Sci U S A (2005) ncbi
not indicated
  • IC; human
  • Neut; human
Sigma anti-E-cadherin mAb DECMA-1 was used in blockting experiments to neutralize E-cadherin activity in human NHEK, HaCaT, or A431 cells, and in immunocytochemistry to detect E-cadherin localization in HaCaT cell cultures.J Biol Chem (2005) ncbi
Genway Biotech
not indicated
  • IHC; human
Genway Biotech mouse anti-E-cadherin antibody was used in immunohistochemistry in order to study the CHD1L-ARHGEF9-Cdc42-EMT pathway involved in hepatocellular carcinoma (HCC) progression and metastasis.J Clin Invest (2010) ncbi
Takara Bio Clontech
not indicated
  • IHC; human
Takara mouse anti-E-cadherin antibody was used in immunohistochemistry to investigate the pathobiological behaviors of gastric mixed-type (MT) carcinomas and gastric carcinogenesis.Virchows Arch (2008) ncbi
not indicated
  • WB; human
  • IC; human
Takara anti-E-cadherin antibody was used in western blot and immunocytochemistry to study that MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface.J Biol Chem (2005) ncbi
Roche Applied Science
not indicated
  • IHC; human
Ventana Medical Systems anti-E-cadherin antibody was used for immunohistochemistry in order to show that a novel translocation involving chromosome 19 causes Xp11.2 translocation renal cell carcinoma.Diagn Pathol (2009) ncbi
not indicated
  • IHC; human
Ventana Platinum mouse anti-human ECAD antibody was used in immunohistochemistry in order to study the role of EMT in the development of early allograft fibrosisJ Am Soc Nephrol (2008) ncbi
others
not indicated
  • IHC; human
Boster anti-E-cadherin polyclonal antibody was used to detect membrane E-cadherin expression in cholangiocarcinoma of patients.Hepatobiliary Pancreat Dis Int (2008) ncbi
others
not indicated
  • WB; human
Cancer Research anti-Cdh1 antibody was used in western blot to investigate the role of APC/C-Cdh1 in the regulation of cell proliferation and glycolysis.Proc Natl Acad Sci U S A (2010) ncbi
not indicated
  • IHC; human
Dr Vania Braga (Imperial College London) anti-E-cadherin antibody was used in immunohistochemistry at 1:1000 dilution to stduy the relationship between the expression of differentiation markers and cadherin-10 expression in human prostate epithelium.Mod Pathol (2008) ncbi
not indicated
  • WB; human
  • IP; human
Dr Meena Jaggi anti-E-cadherin antibody was used in western blot and immunoprecipitation to study the mechanism of E-cadherin phosphorylation by protein kinase D1/protein kinase C.Cancer Res (2005) ncbi
Articles Reviewed
  1. Priyanka Arya et al. (2015). "The endocytic recycling regulatory protein EHD1 Is required for ocular lens development".PMID 26455409
  2. Minoru Takasato et al. (2015). "Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis".PMID 26444236
  3. Daisuke Izumi et al. (2016). "CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer".PMID 26414794
  4. Jason Lizalek et al. (2015). "Lysophosphatidic Acid Stimulates Urokinase Receptor (uPAR/CD87) in Ovarian Epithelial Cancer Cells".PMID 26408685
  5. C O Gamba et al. (2015). "The Relationship Between E-Cadherin and its Transcriptional Repressors in Spontaneously Arising Canine Invasive Micropapillary Mammary Carcinoma".PMID 26385325
  6. Marjana Brkic et al. (2015). "Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases".PMID 26377465
  7. Q Wei et al. (2015). "LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells".PMID 26364604
  8. M S Forbes et al. (2016). "A population of mitochondrion-rich cells in the pars recta of mouse kidney".PMID 26337515
  9. Seiji Mori et al. (2015). "Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells".PMID 26334633
  10. Pamela Maris et al. (2015). "Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer".PMID 26327350
  11. Sangkyu Park et al. (2015). "Thiazovivin, a Rho kinase inhibitor, improves stemness maintenance of embryo-derived stem-like cells under chemically defined culture conditions in cattle".PMID 26307658
  12. Dongfeng Qu et al. (2015). "Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis".PMID 26285154
  13. Jiarong Wang et al. (2015). "Interleukin-1β Promotes Epithelial-Derived Alveolar Elastogenesis via αvβ6 Integrin-Dependent TGF-β Activation".PMID 26279426
  14. Banu Yilmaz Ozgüven et al. (2015). "Solid-pseudopapillary neoplasm of the pancreas: Clinicopathologic and immunohistochemical analysis of nine cases".PMID 26275248
  15. Jing Liu et al. (2015). "Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism".PMID 26256888
  16. Grissel Faura Tellez et al. (2015). "Protocadherin-1 binds to SMAD3 and suppresses TGF-β1-induced gene transcription".PMID 26209277
  17. A Eckhard et al. (2015). "Regulation of the perilymphatic-endolymphatic water shunt in the cochlea by membrane translocation of aquaporin-5".PMID 26208470
  18. Nadia Picot et al. (2015). "Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs".PMID 26207726
  19. Cheryl de Vallière et al. (2015). "The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment".PMID 26206859
  20. Magda S C Fontes et al. (2015). "Arrhythmogenic Remodeling in Murine Models of Deoxycorticosterone Acetate-Salt-Induced and 5/6-Subtotal Nephrectomy-Salt-Induced Cardiorenal Disease".PMID 26195973
  21. Rebecca J Burkhalter et al. (2015). "Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma".PMID 26175151
  22. Teruya Nagahara et al. (2015). "Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells".PMID 26165819
  23. Sandy Azzi et al. (2015). "Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions".PMID 26152359
  24. Damien Maggiorani et al. (2015). "Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells".PMID 26146837
  25. Elanor N Wainwright et al. (2015). "ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation".PMID 26116176
  26. Yuki Sugiyama et al. (2015). "Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation".PMID 26114487
  27. Kristina Preuße et al. (2015). "Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo".PMID 26114479
  28. Carla Bartosch et al. (2015). "Morphological features and mucin expression profile of breast carcinomas with signet-ring cell differentiation".PMID 26092598
  29. Bogdan Tiberius Preca et al. (2015). "A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells".PMID 26077342
  30. Antonis Kourtidis et al. (2015). "Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer".PMID 26067913
  31. Björn Koos et al. (2015). "Proximity-dependent initiation of hybridization chain reaction".PMID 26065580
  32. Stephany El-Hayek et al. (2015). "Follicle-Stimulating Hormone Increases Gap Junctional Communication Between Somatic and Germ-Line Follicular Compartments During Murine Oogenesis".PMID 26063870
  33. Swarnendu Bag et al. (2015). "Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer".PMID 26038241
  34. Alison G Barber et al. (2015). "PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer".PMID 26033689
  35. Alexis Poncy et al. (2015). "Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts".PMID 26033091
  36. Sergio Gonzalez et al. (2015). "In vivo time-lapse imaging of mitochondria in healthy and diseased peripheral myelin sheath".PMID 26031781
  37. B Chen et al. (2015). "N-myc downstream-regulated gene 1 (NDRG1) mediates pomegranate juice protection from apoptosis in hypoxic BeWo cells but not in primary human trophoblasts".PMID 26028238
  38. Vivien Jane Coulson-Thomas et al. (2015). "Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing".PMID 26024086
  39. Sun Ah Kim et al. (2015). "Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro".PMID 26022665
  40. Hoda Zarkoob et al. (2015). "Substrate Stiffness Affects Human Keratinocyte Colony Formation".PMID 26019727
  41. Carla Cicchini et al. (2015). "Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29".PMID 26003733
  42. Genya Izawa et al. (2015). "The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition".PMID 25998899
  43. Bradley C Jackson et al. (2015). "An ELMO2-RhoG-ILK network modulates microtubule dynamics".PMID 25995380
  44. Adelaida R Palla et al. (2015). "The pluripotency factor NANOG promotes the formation of squamous cell carcinomas".PMID 25988972
  45. N Duvall-Noelle et al. (2016). "LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex".PMID 25982273
  46. Fariborz Mortazavi et al. (2015). "Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis".PMID 25956913
  47. Salah Elias et al. (2015). "Huntingtin Is Required for Epithelial Polarity through RAB11A-Mediated Apical Trafficking of PAR3-aPKC".PMID 25942483
  48. Andrea Remo et al. (2015). "Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer".PMID 25928084
  49. Donghwan Jang et al. (2015). "Essential role of flotillin-1 palmitoylation in the intracellular localization and signaling function of IGF-1 receptor".PMID 25908865
  50. Xiaochang Lin et al. (2015). "Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration".PMID 25897964
  51. Maria G Giribaldi et al. (2015). "MTH1 expression is required for effective transformation by oncogenic HRAS".PMID 25893378
  52. Vijaya S Pilli et al. (2015). "Snail-mediated Cripto-1 repression regulates the cell cycle and epithelial-mesenchymal transition-related gene expression".PMID 25889638
  53. Ahmed Bettaieb et al. (2015). "Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice".PMID 25888330
  54. Vengamanaidu Modepalli et al. (2015). "Role of marsupial tammar wallaby milk in lung maturation of pouch young".PMID 25888082
  55. RENAN ORELLANA et al. (2015). "Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells".PMID 25886038
  56. Xiuli Zhang et al. (2015). "Effect of zinc on high glucose-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells".PMID 25872526
  57. Gargi Maity et al. (2015). "Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition".PMID 25867761
  58. Laure Saias et al. (2015). "Cell-Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation".PMID 25855380
  59. Malte Buchholz et al. (2015). "A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer".PMID 25849100
  60. Shaoping Wu et al. (2015). "Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model".PMID 25847918
  61. Maria Teresa Mandara et al. (2015). "Papillary meningioma in the dog: A clinicopathological case series study".PMID 25847284
  62. Jonathan M Charest et al. (2015). "Design and validation of a clinical-scale bioreactor for long-term isolated lung culture".PMID 25818415
  63. Erik Richter et al. (2015). "A multi-omics approach identifies key hubs associated with cell type-specific responses of airway epithelial cells to staphylococcal alpha-toxin".PMID 25816343
  64. Elsa Bazellieres et al. (2015). "Control of cell-cell forces and collective cell dynamics by the intercellular adhesome".PMID 25812522
  65. Daniel Verduzco et al. (2015). "Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance".PMID 25811878
  66. Yujin Kim et al. (2015). "RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung".PMID 25806093
  67. Michael S Dicay et al. (2015). "Interferon-γ suppresses intestinal epithelial aquaporin-1 expression via Janus kinase and STAT3 activation".PMID 25793528
  68. Hong Chao Yan et al. (2015). "Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cells".PMID 25789010
  69. Manabu Kawada et al. (2015). "Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction".PMID 25785838
  70. Helene Strick-Marchand et al. (2015). "A novel mouse model for stable engraftment of a human immune system and human hepatocytes".PMID 25782010
  71. Hye Sook Seo et al. (2015). "Identification of biomarkers regulated by rexinoids (LGD1069, LG100268 and Ro25-7386) in human breast cells using Affymetrix microarray".PMID 25778982
  72. Aleksander Skardal et al. (2015). "Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro".PMID 25777294
  73. Yvette P Geels et al. (2015). "Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium".PMID 25773202
  74. Simon J Conn et al. (2015). "The RNA binding protein quaking regulates formation of circRNAs".PMID 25768908
  75. Anusha H Tennakoon et al. (2015). "Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA)".PMID 25758201
  76. Guo Jun Wang et al. (2015). "The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4".PMID 25753202
  77. Erik Voets et al. (2015). "MASTL promotes cyclin B1 destruction by enforcing Cdc20-independent binding of cyclin B1 to the APC/C".PMID 25750436
  78. Gaëlle Gendronneau et al. (2015). "Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair".PMID 25741714
  79. Yi Chin Toh et al. (2015). "Modulation of integrin and E-cadherin-mediated adhesions to spatially control heterogeneity in human pluripotent stem cell differentiation".PMID 25736499
  80. Anja Rogler et al. (2015). "Functional analyses and prognostic significance of SFRP1 expression in bladder cancer".PMID 25732201
  81. S S Islam et al. (2015). "Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer".PMID 25728352
  82. Sun ErLin et al. (2015). "Musashi-1 maintains blood-testis barrier structure during spermatogenesis and regulates stress granule formation upon heat stress".PMID 25717188
  83. Jian Hong Fang et al. (2015). "A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner".PMID 25711742
  84. Huihui Wang et al. (2015). "Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ".PMID 25697482
  85. Raju R Rayavarapu et al. (2015). "The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment".PMID 25681438
  86. Ming Liang Oon et al. (2015). "Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast".PMID 25677743
  87. Yu Na Kang et al. (2015). "Microcystic stromal tumor of the ovary with mutation in exon 3 of β-catenin: a case report".PMID 25675179
  88. Michiel Boekhout et al. (2015). "Nek2A destruction marks APC/C activation at the prophase-to-prometaphase transition by spindle-checkpoint-restricted Cdc20".PMID 25673878
  89. Hayeong Kwon et al. (2015). "Fatty acylated caveolin-2 is a substrate of insulin receptor tyrosine kinase for insulin receptor substrate-1-directed signaling activation".PMID 25667086
  90. Jiro Kitamura et al. (2015). "Chronic lung injury by constitutive expression of activation-induced cytidine deaminase leads to focal mucous cell metaplasia and cancer".PMID 25659078
  91. Dat Nguyen et al. (2015). "Notch1 phenotype and clinical stage progression in non-small cell lung cancer".PMID 25653136
  92. Marcel Kap et al. (2015). "A reference image-based method for optimization of clinical immunohistochemistry".PMID 25640638
  93. Paul J Hauser et al. (2015). "Abnormalities in Expression of Structural, Barrier and Differentiation Related Proteins, and Chondroitin Sulfate in Feline and Human Interstitial Cystitis".PMID 25636658
  94. Roselyne Y Wagner et al. (2015). "Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo".PMID 25634357
  95. Kathy Qi Cai et al. (2015). "Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice".PMID 25622902
  96. Shing Hwa Liu et al. (2015). "Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition".PMID 25619450
  97. Huiming Peng et al. (2015). "Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis".PMID 25616357
  98. Stina Lindén et al. (2015). "Terbium-based time-gated Förster resonance energy transfer imaging for evaluating protein-protein interactions on cell membranes".PMID 25612290
  99. Won Kyung Kang et al. (2015). "Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse".PMID 25609245
  100. Michael A Schumacher et al. (2015). "The use of murine-derived fundic organoids in studies of gastric physiology".PMID 25605613
  101. Alejandro A Arriagada et al. (2015). "Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species".PMID 25594695
  102. Masanori Miyata et al. (2015). "Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M".PMID 25585690
  103. Xianhua Xu et al. (2015). "Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancer".PMID 25574191
  104. Simona Gurzu et al. (2015). "Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity".PMID 25556597
  105. Mateja Erdani Kreft et al. (2015). "The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function".PMID 25555374
  106. Benjamin J Caldwell et al. (2014). "Tropomyosin isoforms support actomyosin biogenesis to generate contractile tension at the epithelial zonula adherens".PMID 25545457
  107. Shoichiro Tange et al. (2014). "JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines".PMID 25542019
  108. Petter Angell Olsen et al. (2014). "Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells".PMID 25536063
  109. X Gong et al. (2015). "Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness".PMID 25531322
  110. Xiaomei Yuan et al. (2015). "IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa".PMID 25527788
  111. Yikwon Kim et al. (2014). "Comparative proteomic profiling of pancreatic ductal adenocarcinoma cell lines".PMID 25518923
  112. Elisa Vitiello et al. (2014). "The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell-cell adhesion".PMID 25518808
  113. Arun Satelli et al. (2015). "Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression".PMID 25516888
  114. Akihiro Watari et al. (2015). "Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers".PMID 25513955
  115. Joshua D Powell et al. (2015). "Construction of an in vitro primary lung co-culture platform derived from New Zealand white rabbits".PMID 25491427
  116. D Golden et al. (2015). "Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm".PMID 25486430
  117. Johnathan K Smid et al. (2015). "Periostin induces pancreatic regeneration".PMID 25485969
  118. Edward Carter et al. (2014). "Phosphoinositide 3-kinase alpha-dependent regulation of branching morphogenesis in murine embryonic lung: evidence for a role in determining morphogenic properties of FGF7".PMID 25460003
  119. Ben Davidson et al. (2015). "The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions".PMID 25455994
  120. Ana Catarina Figueira et al. (2014). "Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas".PMID 25424750
  121. David J Guckenberger et al. (2015). "High-density self-contained microfluidic KOALA kits for use by everyone".PMID 25424385
  122. Xingxing Liu et al. (2014). "Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions".PMID 25422594
  123. Laura Raiko et al. (2009). "Tight junctions in Hailey-Hailey and Darier's diseases".PMID 25386233
  124. Yucel Akgul et al. (2014). "Hyaluronan in cervical epithelia protects against infection-mediated preterm birth".PMID 25384213
  125. Eric Ciamporcero et al. (2015). "Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models".PMID 25381264
  126. Dorothée Poidatz et al. (2015). "Trophoblast syncytialisation necessitates mitochondrial function through estrogen-related receptor-γ activation".PMID 25376642
  127. Miju Kim et al. (2014). "The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis".PMID 25367221
  128. Boon Seng Soh et al. (2014). "N-cadherin prevents the premature differentiation of anterior heart field progenitors in the pharyngeal mesodermal microenvironment".PMID 25367124
  129. Annalisa Pezzolo et al. (2014). "Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia".PMID 25362644
  130. Kae Jiun Chang et al. (2014). "Glial ankyrins facilitate paranodal axoglial junction assembly".PMID 25362471
  131. Elie Akoury et al. (2015). "NLRP7 and KHDC3L, the two maternal-effect proteins responsible for recurrent hydatidiform moles, co-localize to the oocyte cytoskeleton".PMID 25358348
  132. Veronica Preda et al. (2015). "The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis".PMID 25355426
  133. Nicholas B Griner et al. (2015). "ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer".PMID 25344575
  134. Kamini Kunasegaran et al. (2014). "Transcriptional repressor Tbx3 is required for the hormone-sensing cell lineage in mammary epithelium".PMID 25343378
  135. Qiang Sun et al. (2014). "Competition between human cells by entosis".PMID 25342560
  136. Qiang Sun et al. (2014). "Induction of entosis by epithelial cadherin expression".PMID 25342558
  137. Sung Suk Suh et al. (2014). "FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs".PMID 25340791
  138. Debora Soncini et al. (2014). "Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity".PMID 25331943
  139. Cristina Mariana Calangiu et al. (2014). "The expression of CK19, vimentin and E-cadherin in differentiated thyroid carcinomas".PMID 25329121
  140. Jimena Laporta et al. (2014). "Peripheral serotonin regulates maternal calcium trafficking in mammary epithelial cells during lactation in mice".PMID 25299122
  141. Amanda P Beck et al. (2014). "Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta)".PMID 25296018
  142. Chuifeng Fan et al. (2015). "Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1".PMID 25263389
  143. Yan Sun et al. (2015). "MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer".PMID 25230372
  144. Yuan Cao et al. (2014). "BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity".PMID 25224959
  145. Elanor N Wainwright et al. (2014). "Primary cilia function regulates the length of the embryonic trunk axis and urogenital field in mice".PMID 25224227
  146. Jehn Chuan Lee et al. (2014). "N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma".PMID 25218595
  147. Matthew G Rubashkin et al. (2014). "Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate".PMID 25183785
  148. Juan Li et al. (2014). "Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion".PMID 25178656
  149. Yohannes Hagos et al. (2014). "HNF4α induced chemosensitivity to oxaliplatin and 5-FU mediated by OCT1 and CNT3 in renal cell carcinoma".PMID 25175346
  150. J Tang et al. (2014). "Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition".PMID 25174891
  151. Vadim L Zorin et al. (2014). "Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts".PMID 25167539
  152. Anna B Wennerström et al. (2014). "Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines".PMID 25148029
  153. Mateja Erdani Kreft et al. (2015). "The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model".PMID 25145337
  154. Tatsushi Kodama et al. (2014). "A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell line".PMID 25144242
  155. Hiroki Ishii et al. (2014). "Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms".PMID 25143390
  156. E I Kaygusuz et al. (2015). "Immunohistochemical expression of CD44 standard and E-cadherin in atypical leiomyoma and leiomyosarcoma of the uterus".PMID 25140670
  157. Josephine Y Fang et al. (2014). "Tumor bioengineering using a transglutaminase crosslinked hydrogel".PMID 25133673
  158. Gang Lu et al. (2014). "Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor".PMID 25117710
  159. Lilian Gonçalves dos Reis Bastos et al. (2014). "Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate Wnt/β-catenin pathway".PMID 25103643
  160. Arianna Crespi et al. (2015). "POF1B localizes to desmosomes and regulates cell adhesion in human intestinal and keratinocyte cell lines".PMID 25084053
  161. Kavitha Balaji et al. (2014). "The RAB5-GEF function of RIN1 regulates multiple steps during Listeria monocytogenes infection".PMID 25082076
  162. Ikue Nagakura et al. (2014). "STAT1 regulates the homeostatic component of visual cortical plasticity via an AMPA receptor-mediated mechanism".PMID 25080587
  163. Augustine Chen et al. (2014). "E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition".PMID 25079037
  164. André Said et al. (2015). "Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro".PMID 25059418
  165. Guillaume Pidoux et al. (2014). "A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion".PMID 25052094
  166. P Owens et al. (2015). "Inhibition of BMP signaling suppresses metastasis in mammary cancer".PMID 24998846
  167. María Costales et al. (2015). "Establishment and characterization of an orthotopic sinonasal squamous cell carcinoma mouse model".PMID 24990098
  168. Jinlin Liu et al. (2014). "CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo".PMID 24979261
  169. Luca Azzolin et al. (2014). "YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response".PMID 24976009
  170. Wu Liang et al. (2014). "CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition".PMID 24968949
  171. Abbye E McEwen et al. (2014). "E-cadherin phosphorylation occurs during its biosynthesis to promote its cell surface stability and adhesion".PMID 24966173
  172. Monika E Dolega et al. (2014). "Facile bench-top fabrication of enclosed circular microchannels provides 3D confined structure for growth of prostate epithelial cells".PMID 24945245
  173. Katarzyna Zielniok et al. (2014). "Functional interactions between 17 β -estradiol and progesterone regulate autophagy during acini formation by bovine mammary epithelial cells in 3D cultures".PMID 24895572
  174. Shuhei Enjoji et al. (2014). "Regulation of epithelial cell tight junctions by protease-activated receptor 2".PMID 24881651
  175. Bhavani S Kowtharapu et al. (2014). "Corneal epithelial and neuronal interactions: role in wound healing".PMID 24880142
  176. Sònia Bassagañas et al. (2014). "Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function".PMID 24878505
  177. Mi Sook Lee et al. (2014). "Snail1 induced in breast cancer cells in 3D collagen I gel environment suppresses cortactin and impairs effective invadopodia formation".PMID 24861866
  178. Cristian P Moiola et al. (2014). "Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice".PMID 24842953
  179. Sanaz Attarha et al. (2014). "Mammalian sterile-like 1 kinase inhibits TGFβ and EGF‑dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells".PMID 24841766
  180. Chen Zhang et al. (2014). "Helicobacter pylori dwelling on the apical surface of gastrointestinal epithelium damages the mucosal barrier through direct contact".PMID 24826891
  181. Victoria A Elliott et al. (2014). "Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model".PMID 24823486
  182. O Durak et al. (2015). "Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin".PMID 24821222
  183. Ramadevi Subramani et al. (2014). "Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis".PMID 24809702
  184. Angelina E Altshuler et al. (2014). "Transmural intestinal wall permeability in severe ischemia after enteral protease inhibition".PMID 24805256
  185. Yukari Miki et al. (2014). "Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma".PMID 24802113
  186. Samil Jung et al. (2014). "Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells".PMID 24789658
  187. Ying Na Bao et al. (2014). "Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis".PMID 24763226
  188. Rui Wang et al. (2014). "Live cell imaging of in vitro human trophoblast syncytialization".PMID 24740598
  189. Giacomo Rossi et al. (2014). "Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease".PMID 24722235
  190. Gwenneg Kerdivel et al. (2014). "Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines".PMID 24721635
  191. Robert S Ohgami et al. (2014). "E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms".PMID 24713736
  192. Eloy Bejarano et al. (2014). "Connexins modulate autophagosome biogenesis".PMID 24705551
  193. Ana Serna et al. (2014). "Functional inhibition of aquaporin-3 with a gold-based compound induces blockage of cell proliferation".PMID 24676973
  194. J Diessner et al. (2014). "Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)".PMID 24675467
  195. Rodolfo Villarreal-Calderon et al. (2014). "Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis".PMID 24656654
  196. Marta Truffi et al. (2014). "RPTPα controls epithelial adherens junctions, linking E-cadherin engagement to c-Src-mediated phosphorylation of cortactin".PMID 24652832
  197. E Mato et al. (2014). "ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1)".PMID 24643400
  198. Nathalie Wojtalewicz et al. (2014). "A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding".PMID 24625754
  199. Douglas A Chapnick et al. (2014). "Leader cell positioning drives wound-directed collective migration in TGFβ-stimulated epithelial sheets".PMID 24623725
  200. John D Clarke et al. (2014). "Synergistic interaction between genetics and disease on pravastatin disposition".PMID 24613363
  201. Dahu Chen et al. (2014). "miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion".PMID 24586203
  202. Fabrice Prin et al. (2014). "Hox proteins drive cell segregation and non-autonomous apical remodelling during hindbrain segmentation".PMID 24574009
  203. T Yoshida et al. (2014). "Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states".PMID 24569463
  204. Wiebke K Peitsch et al. (2014). "Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells".PMID 24558503
  205. Lukas Fliedl et al. (2014). "Novel human renal proximal tubular cell line for the production of complex proteins".PMID 24553072
  206. Tim Baumann et al. (2014). "Glutathione-conjugated sulfanylalkanols are substrates for ABCC11 and γ-glutamyl transferase 1: a potential new pathway for the formation of odorant precursors in the apocrine sweat gland".PMID 24533866
  207. Agoston T Agoston et al. (2014). "Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion".PMID 24529328
  208. Johanna J Salomon et al. (2014). "The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier".PMID 24524365
  209. M M P Rodrigues et al. (2013). "Role of adhesion molecules and proliferation hyperplasic, pre neoplastic and neoplastic lesions in canine prostate".PMID 24511741
  210. Parisa Hesami et al. (2014). "A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone".PMID 24510218
  211. Birgit Berkenkamp et al. (2014). "In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells".PMID 24505380
  212. L Shen et al. (2014). "Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer".PMID 24492480
  213. Ang Li et al. (2014). "Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes".PMID 24462734
  214. Sylvia A Hilliard et al. (2014). "Mdm2 is required for maintenance of the nephrogenic niche".PMID 24440154
  215. Wenhao Weng et al. (2014). "Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin".PMID 24424621
  216. Renata Bordeira-Carriço et al. (2014). "Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA".PMID 24424122
  217. Jody Groenendyk et al. (2014). "Disrupted WNT signaling in mouse embryonic stem cells in the absence of calreticulin".PMID 24415131
  218. Fabrizio D'Anselmi et al. (2013). "Microenvironment promotes tumor cell reprogramming in human breast cancer cell lines".PMID 24386275
  219. Shin Miura et al. (2014). "CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells".PMID 24384474
  220. Justin M Balko et al. (2014). "Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets".PMID 24356096
  221. Y Yu et al. (2014). "Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling".PMID 24335925
  222. M Takasato et al. (2014). "Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney".PMID 24335651
  223. Man Gao et al. (2013). "The distinct expression patterns of claudin-10, -14, -17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues".PMID 24325792
  224. Sun A Kim et al. (2014). "Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential".PMID 24321526
  225. Adrien Rousseau et al. (2013). "TRAF4 is a novel phosphoinositide-binding protein modulating tight junctions and favoring cell migration".PMID 24311986
  226. Heath Jones et al. (2014). "Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing".PMID 24300538
  227. Israel Cañadas et al. (2014). "Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer".PMID 24284055
  228. Honor J Hugo et al. (2013). "Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells".PMID 24283570
  229. Magdalena Kasendra et al. (2014). "Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium".PMID 24273043
  230. Suman Karki et al. (2014). "Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis".PMID 24265486
  231. Tomoko Shiobara et al. (2013). "The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin".PMID 24260326
  232. Wei ren Luo et al. (2014). "Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma".PMID 24248285
  233. E Zaganjor et al. (2014). "Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells".PMID 24240690
  234. Jan F Richter et al. (2014). "Diets high in fermentable protein and fibre alter tight junction protein composition with minor effects on barrier function in piglet colon".PMID 24229735
  235. L J Dawes et al. (2014). "Interactions between lens epithelial and fiber cells reveal an intrinsic self-assembly mechanism".PMID 24211762
  236. Hsan Au Wu et al. (2013). "Mitogen-activated protein kinase signaling mediates phosphorylation of polycomb ortholog Cbx7".PMID 24194518
  237. Chonggao Yin et al. (2013). "RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition".PMID 24177755
  238. Nathan McLaughlin et al. (2014). "In situ histone landscape of nephrogenesis".PMID 24169366
  239. Petros D Grivas et al. (2013). "Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer".PMID 24166682
  240. A Formosa et al. (2014). "MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells".PMID 24166498
  241. B de Craene et al. (2014). "Epidermal Snail expression drives skin cancer initiation and progression through enhanced cytoprotection, epidermal stem/progenitor cell expansion and enhanced metastatic potential".PMID 24162662
  242. Qiao Song Zheng et al. (2014). "Wt1 deficiency causes undifferentiated spermatogonia accumulation and meiotic progression disruption in neonatal mice".PMID 24129152
  243. Lu Yu et al. (2014). "Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma".PMID 24079261
  244. Kristi Bray et al. (2013). "Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration".PMID 24074261
  245. Mi Jin Gu et al. (2014). "Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma".PMID 24062361
  246. K Yasuno et al. (2014). "Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples".PMID 24060153
  247. William L Haisler et al. (2013). "Three-dimensional cell culturing by magnetic levitation".PMID 24030442
  248. Inga Karch et al. (2013). "Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?".PMID 24023670
  249. A P F R L Bracarense et al. (2013). "Helicobacter spp. infection induces changes in epithelial proliferation and E-cadherin expression in the gastric mucosa of pigs".PMID 24011902
  250. Victoria J Findlay et al. (2014). "Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer".PMID 23996472
  251. Wei Bao et al. (2013). "Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma".PMID 23936232
  252. Manish Kumar et al. (2013). "NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells".PMID 23935876
  253. C Allison Stewart et al. (2013). "CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development".PMID 23904126
  254. Cheng Chang et al. (2013). "Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin β4".PMID 23878399
  255. Yongjun Yin et al. (2013). "Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3".PMID 23867472
  256. Elina Siljamäki et al. (2014). "p38δ mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes".PMID 23856837
  257. Joseph C Chen et al. (2013). "Coculturing human endometrial epithelial cells and stromal fibroblasts alters cell-specific gene expression and cytokine production".PMID 23849844
  258. Ching Wen Chang et al. (2013). "Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death".PMID 23843890
  259. Golan Bubis et al. (2013). "A new Ki-67 / E-cadherin cocktail reduces inter-observer variation of the calculated proliferative index".PMID 23832820
  260. Sabine M Brouxhon et al. (2014). "Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers".PMID 23776059
  261. Mario A Shields et al. (2013). "Snail cooperates with KrasG12D to promote pancreatic fibrosis".PMID 23761168
  262. F Sangar et al. (2014). "Involvement of small ArfGAP1 (SMAP1), a novel Arf6-specific GTPase-activating protein, in microsatellite instability oncogenesis".PMID 23752192
  263. Yu Huan Tsai et al. (2013). "Murinization of internalin extends its receptor repertoire, altering Listeria monocytogenes cell tropism and host responses".PMID 23737746
  264. Ron C J Schackmann et al. (2013). "Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling".PMID 23733751
  265. Melissa Gillette et al. (2013). "P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation".PMID 23717689
  266. Yongli Shi et al. (2013). "Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma".PMID 23706092
  267. Yosuke Harazono et al. (2013). "miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2".PMID 23690952
  268. Kazutetsu Aoshiba et al. (2013). "Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury".PMID 23688655
  269. Tian Ma et al. (2013). "Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer".PMID 23686769
  270. Natalya N Pavlova et al. (2013). "A role for PVRL4-driven cell-cell interactions in tumorigenesis".PMID 23682311
  271. Salomé S Pinho et al. (2013). "E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V".PMID 23671930
  272. Christopher Boehlke et al. (2013). "Kif3a guides microtubular dynamics, migration and lumen formation of MDCK cells".PMID 23658710
  273. Jiyoung Park et al. (2013). "Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours".PMID 23629957
  274. Henry Puerta-Guardo et al. (2013). "The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability".PMID 23616663
  275. Z Zhou et al. (2013). "The proprotein convertase furin is required for trophoblast syncytialization".PMID 23598405
  276. Hang Xiao et al. (2013). "Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy".PMID 23585831
  277. Bettina Maier et al. (2013). "The novel actin/focal adhesion-associated protein MISP is involved in mitotic spindle positioning in human cells".PMID 23574715
  278. Valgardur Sigurdsson et al. (2013). "Expression and functional role of sprouty-2 in breast morphogenesis".PMID 23573284
  279. C Vasconcelos-Nóbrega et al. (2013). "E-cadherin and β-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice".PMID 23548313
  280. Hong Jian Jin et al. (2013). "Androgen receptor-independent function of FoxA1 in prostate cancer metastasis".PMID 23539448
  281. John R Griffin et al. (2013). "Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin".PMID 23525614
  282. Su Ren Chen et al. (2013). "Disruption of genital ridge development causes aberrant primordial germ cell proliferation but does not affect their directional migration".PMID 23497137
  283. Stefanie Michael et al. (2013). "Tissue engineered skin substitutes created by laser-assisted bioprinting form skin-like structures in the dorsal skin fold chamber in mice".PMID 23469227
  284. Kanako Sakaguchi et al. (2013). "Intestinal undifferentiated carcinoma in a red-crowned crane (Grus japonensis)".PMID 23391509
  285. Lucy J Dawes et al. (2013). "Wnt-frizzled signaling is part of an FGF-induced cascade that promotes lens fiber differentiation".PMID 23385791
  286. Emad A Rakha et al. (2013). "Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study".PMID 23347178
  287. Salih Taskin et al. (2012). "Roles of E-cadherin and cyclooxygenase enzymes in predicting different survival patterns of optimally cytoreduced serous ovarian cancer patients".PMID 23317244
  288. Sanjeev Shukla et al. (2013). "Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression".PMID 23308245
  289. Cristiana Angelucci et al. (2012). "Epithelial-stromal interactions in human breast cancer: effects on adhesion, plasma membrane fluidity and migration speed and directness".PMID 23251387
  290. Yao Peng Wang et al. (2012). "Lentivirus-mediated shRNA interference targeting SLUG inhibits lung cancer growth and metastasis".PMID 23244088
  291. Ian J Majewski et al. (2013). "An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer".PMID 23208944
  292. Kristin Gordon et al. (2013). "Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis".PMID 23190894
  293. Suzanah C Boyd et al. (2013). "Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion".PMID 23190890
  294. Brian D Lawrence et al. (2012). "Silk film topography directs collective epithelial cell migration".PMID 23185573
  295. Mariko Fukuma et al. (2013). "Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells".PMID 23127514
  296. Delphine Garnier et al. (2012). "Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor".PMID 23118232
  297. Pierina Visciano et al. (2013). "Detection of yessotoxin by three different methods in Mytilus galloprovincialis of Adriatic Sea, Italy".PMID 23063482
  298. Krista J Queen et al. (2013). "Epstein-Barr virus-induced epigenetic alterations following transient infection".PMID 23047626
  299. L Lu et al. (2012). "Loss of E-cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: possible implication in the enhanced invasive ability".PMID 23047512
  300. Cassy M Spiller et al. (2012). "Endogenous Nodal signaling regulates germ cell potency during mammalian testis development".PMID 23034635
  301. Yoko Takahashi et al. (2012). "Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma".PMID 23032744
  302. Marybeth Langer et al. (2012). "Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function".PMID 23027535
  303. Yuji Piao et al. (2012). "Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype".PMID 22965162
  304. Thomas U Ahearn et al. (2012). "A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients".PMID 22964475
  305. Antonio Peramo et al. (2013). "Visible effects of rapamycin (sirolimus) on human skin explants in vitro".PMID 22960739
  306. Rui M Gil da Costa et al. (2014). "Ptaquiloside-induced early-stage urothelial lesions show increased cell proliferation and intact β-catenin and E-cadherin expression".PMID 22859263
  307. Richard C Krolewski et al. (2013). "Global expression profiling of globose basal cells and neurogenic progression within the olfactory epithelium".PMID 22847514
  308. Julia Y S Tsang et al. (2012). "E-cadherin expression in the epithelial components of mammary phyllodes tumors".PMID 22820000
  309. Jianliang Xu et al. (2012). "ZO-1 regulates Erk, Smad1/5/8, Smad2, and RhoA activities to modulate self-renewal and differentiation of mouse embryonic stem cells".PMID 22782886
  310. I I Mackowiak et al. (2012). "E-cadherin in canine mast cell tumors: decreased expression and altered subcellular localization in Grade 3 tumors".PMID 22766308
  311. Lincon A Stamp et al. (2012). "The GCTM-5 epitope associated with the mucin-like glycoprotein FCGBP marks progenitor cells in tissues of endodermal origin".PMID 22761039
  312. Se Min Jang et al. (2012). "Clinicopathological significance of CADM4 expression, and its correlation with expression of E-cadherin and Ki-67 in colorectal adenocarcinomas".PMID 22718847
  313. Jeroen F Vermeulen et al. (2012). "Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer".PMID 22662240
  314. Chih Hsien Wu et al. (2012). "Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation".PMID 22648416
  315. Nicholas P Tobin et al. (2012). "Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information".PMID 22647349
  316. Laura Raiko et al. (2012). "Hailey-Hailey disease and tight junctions: Claudins 1 and 4 are regulated by ATP2C1 gene encoding Ca(2+) /Mn(2+) ATPase SPCA1 in cultured keratinocytes".PMID 22639968
  317. Yueying Liu et al. (2012). "Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells".PMID 22593767
  318. Fortunata Iacopino et al. (2012). "Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system".PMID 22593435
  319. Thomas U Ahearn et al. (2012). "Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms".PMID 22539608
  320. Anne Vincent-Salomon et al. (2012). "High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients".PMID 22531230
  321. Aikaterini Stoyianni et al. (2012). "Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility".PMID 22493359
  322. Henning Karlsson et al. (2012). "Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system".PMID 22487097
  323. Daniel T Chang et al. (2012). "Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features".PMID 22481281
  324. Walter Lisch et al. (2012). "Franceschetti hereditary recurrent corneal erosion".PMID 22402249
  325. Joseph D Dukes et al. (2012). "The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells".PMID 22396724
  326. Fiach C O'Mahony et al. (2012). "The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma".PMID 22363672
  327. Chiara Palka Bayard de Volo et al. (2012). "16q22.1 microdeletion detected by array-CGH in a family with mental retardation and lobular breast cancer".PMID 22326525
  328. Teresa M DesRochers et al. (2012). "The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma".PMID 22207358
  329. Jing Zhang et al. (2011). "Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis".PMID 22175900
  330. Wenxian Zhi et al. (2011). "The MLH1 2101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males".PMID 22136435
  331. Christopher A Maxwell et al. (2011). "Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer".PMID 22110403
  332. Anh Thu Nguyen Hoang et al. (2012). "Dendritic cell functional properties in a three-dimensional tissue model of human lung mucosa".PMID 22101763
  333. Raghad Samir et al. (2012). "Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia".PMID 22067748
  334. Magdalena M Grabowska et al. (2012). "EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells".PMID 22024284
  335. Daniel J Schneider et al. (2012). "Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition".PMID 21990376
  336. Georgios Nikitas et al. (2011). "Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin".PMID 21967767
  337. Orsi Giricz et al. (2012). "Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity".PMID 21953071
  338. Regina B Troyanovsky et al. (2011). "α-Catenin contributes to the strength of E-cadherin-p120 interactions".PMID 21937720
  339. Ana Paula F L Bracarense et al. (2012). "Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets".PMID 21936967
  340. Valgardur Sigurdsson et al. (2011). "Endothelial induced EMT in breast epithelial cells with stem cell properties".PMID 21915264
  341. Meike de Wit et al. (2012). "Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression".PMID 21890811
  342. Soraya Sin et al. (2011). "Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis".PMID 21832234
  343. Eric H Holbrook et al. (2011). "Immunohistochemical characterization of human olfactory tissue".PMID 21792956
  344. Markus D Lacher et al. (2011). "ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor".PMID 21791114
  345. Yusuke Kobayashi et al. (2011). "Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12".PMID 21787741
  346. Joseph D Dukes et al. (2011). "Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells".PMID 21757541
  347. Sandra S Essbauer et al. (2011). "A new permanent cell line derived from the bank vole (Myodes glareolus) as cell culture model for zoonotic viruses".PMID 21729307
  348. Sarah M Russell et al. (2011). "USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics".PMID 21719345
  349. Hira Lal Goel et al. (2011). "Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland".PMID 21693513
  350. Johannes Betge et al. (2011). "Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis".PMID 21687951
  351. A K Lindström et al. (2011). "Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium".PMID 21632100
  352. Tong Ding et al. (2011). "Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection".PMID 21480209
  353. Biljana Jovov et al. (2011). "Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease".PMID 21448147
  354. Mark A Eckert et al. (2011). "Twist1-induced invadopodia formation promotes tumor metastasis".PMID 21397860
  355. E Ferreira et al. (2012). "Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs".PMID 21282668
  356. Min Chen et al. (2011). "Methyl deficient diet aggravates experimental colitis in rats".PMID 21199330
  357. Hanna C Diehl et al. (2007). "A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery".PMID 21136611
  358. Kar Lok Kong et al. (2010). "Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma".PMID 20978196
  359. Tomohiro Onodera et al. (2010). "Btbd7 regulates epithelial cell dynamics and branching morphogenesis".PMID 20671187
  360. Qing Li Kong et al. (2010). "Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma".PMID 20532215
  361. Kjersti Flatmark et al. (2010). "Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models".PMID 20338618
  362. LeiLei Chen et al. (2010). "CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients".PMID 20335658
  363. Hossein Aleyasin et al. (2010). "DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway".PMID 20133695
  364. Angeles Almeida et al. (2010). "E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation".PMID 20080744
  365. David J Shields et al. (2010). "RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia".PMID 20080647
  366. Anna Lyubimova et al. (2010). "Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice".PMID 20071778
  367. Romaine I Fernando et al. (2010). "The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells".PMID 20071775
  368. Shinako Araki et al. (2010). "TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer".PMID 19955655
  369. Alexander E Finlayson et al. (2009). "A cell motility screen reveals role for MARCKS-related protein in adherens junction formation and tumorigenesis".PMID 19924305
  370. Douglas S Micalizzi et al. (2009). "The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling".PMID 19726885
  371. Henry B Armah et al. (2009). "Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature".PMID 19450277
  372. DaMing Gao et al. (2009). "Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction".PMID 19270695
  373. Yuanguang Meng et al. (2009). "Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors".PMID 19257909
  374. Yoonseok Kam et al. (2009). "Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools".PMID 19238201
  375. Jiang Yang et al. (2009). "Lipocalin 2 promotes breast cancer progression".PMID 19237579
  376. Susanne J Rogers et al. (2009). "Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck".PMID 19197951
  377. Sugiko Watanabe et al. (2009). "HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells".PMID 19179606
  378. Olivier Béaslas et al. (2009). "Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1".PMID 19169357
  379. Zhongjian Xie et al. (2009). "Phosphatidylinositol-4-phosphate 5-kinase 1alpha mediates extracellular calcium-induced keratinocyte differentiation".PMID 19158393
  380. Chaoyang Jin et al. (2009). "Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness".PMID 19155312
  381. Helene Faustrup et al. (2009). "USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin".PMID 19124652
  382. Sheng Ge et al. (2009). "APC/C- and Mad2-mediated degradation of Cdc20 during spindle checkpoint activation".PMID 19098431
  383. Xue Qing Wang et al. (2009). "Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9".PMID 19037103
  384. E E Hoskins et al. (2009). "Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture".PMID 19015634
  385. Timo Liebig et al. (2009). "RhoE Is required for keratinocyte differentiation and stratification".PMID 18923151
  386. Sylvie Thuault et al. (2008). "HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition".PMID 18832382
  387. Joseph L Charest et al. (2009). "Cadherin-mediated cell-cell contact regulates keratinocyte differentiation".PMID 18754040
  388. Nasim Shweke et al. (2008). "Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration".PMID 18688035
  389. Oliver Driemel et al. (2008). "Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma".PMID 18671846
  390. Mary L Holtz et al. (2008). "Endothelial-specific ablation of serum response factor causes hemorrhaging, yolk sac vascular failure, and embryonic lethality".PMID 18570667
  391. C Marchio et al. (2008). "Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast".PMID 18484683
  392. Matthew J Vitalone et al. (2008). "Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage".PMID 18480317
  393. Kirsten D Mertz et al. (2008). "Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer".PMID 18478571
  394. Young Kwang Chae et al. (2008). "Expression of aquaporin 5 (AQP5) promotes tumor invasion in human non small cell lung cancer".PMID 18478076
  395. P T Simpson et al. (2008). "Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas".PMID 18473330
  396. Emad A Rakha et al. (2008). "Expression of BRCA1 protein in breast cancer and its prognostic significance".PMID 18400253
  397. R T Bryan et al. (2008). "Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies".PMID 18393367
  398. Sin Ae Lee et al. (2008). "Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma".PMID 18357344
  399. Hua Chuan Zheng et al. (2008). "Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas".PMID 18266006
  400. Qiang Li et al. (2008). "Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma".PMID 18234642
  401. Aram F Hezel et al. (2008). "Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms".PMID 18227155
  402. Marjorie M Walker et al. (2008). "The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer".PMID 18084254
  403. Akiko Onishi et al. (2008). "STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells".PMID 17961551
  404. Dolores D Mruk et al. (2007). "Rab4A GTPase catenin interactions are involved in cell junction dynamics in the testis".PMID 17494101
  405. Janeen Azare et al. (2007). "Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6".PMID 17438134
  406. Marlowe S Tessmer et al. (2007). "KLRG1 binds cadherins and preferentially associates with SHIP-1".PMID 17307799
  407. Amy L Donner et al. (2007). "Pax6 is misexpressed in Sox1 null lens fiber cells".PMID 17306631
  408. Hong C Li et al. (2007). "Identification of a novel signal in the cytoplasmic tail of the Na+:HCO3- cotransporter NBC1 that mediates basolateral targeting".PMID 17182531
  409. Anna Sergeeva et al. (2006). "Display technologies: application for the discovery of drug and gene delivery agents".PMID 17123658
  410. Stefan Grotegut et al. (2006). "Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail".PMID 16858414
  411. D Bocangel et al. (2006). "Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells".PMID 16783343
  412. Mariam Dohadwala et al. (2006). "Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer".PMID 16707460
  413. T Pukrop et al. (2006). "Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines".PMID 16569699
  414. E A Rakha et al. (2006). "Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation".PMID 16429394
  415. Shaji Abraham et al. (2006). "Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder".PMID 16428472
  416. Polly J Phillips-Mason et al. (2006). "The receptor protein-tyrosine phosphatase PTPmu interacts with IQGAP1".PMID 16380380
  417. Catharine C Calkins et al. (2006). "Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies".PMID 16377623
  418. Anja Duursma et al. (2005). "p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation".PMID 16055707
  419. Wei Meng Zhao et al. (2005). "Anillin is a substrate of anaphase-promoting complex/cyclosome (APC/C) that controls spatial contractility of myosin during late cytokinesis".PMID 16040610
  420. Jianfei Qi et al. (2005). "Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway".PMID 15987741
  421. Olivera Stojadinovic et al. (2005). "Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing".PMID 15972952
  422. Thorsten Maretzky et al. (2005). "ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation".PMID 15958533
  423. Kameswaran Surendran et al. (2005). "Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis".PMID 15944336
  424. Agnieszka K Witkiewicz et al. (2005). "Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis".PMID 15941950
  425. Eri Mizuhara et al. (2005). "MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface".PMID 15908431
  426. Takashi Hoshino et al. (2005). "Regulation of E-cadherin endocytosis by nectin through afadin, Rap1, and p120ctn".PMID 15857834
  427. Nicolas Tricaud et al. (2005). "Adherens junctions in myelinating Schwann cells stabilize Schmidt-Lanterman incisures via recruitment of p120 catenin to E-cadherin".PMID 15800180
  428. Xinyu Chen et al. (2005). "Par-3 controls tight junction assembly through the Rac exchange factor Tiam1".PMID 15723052
  429. Nancy Gavert et al. (2005). "L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers".PMID 15716380
  430. Meena Jaggi et al. (2005). "E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer".PMID 15695390
  431. Edith Hintermann et al. (2005). "Integrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes".PMID 15579904
  432. David M Bryant et al. (2005). "Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin".PMID 15509650
  433. Rainer Kuefer et al. (2003). "The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer".PMID 14695147
  434. Sang Uk Han et al. (2004). "Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer".PMID 14647420
  435. Cara J Gottardi et al. (2004). "Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions".PMID 14613891
  436. Michael A Davis et al. (2003). "A core function for p120-catenin in cadherin turnover".PMID 14610055
  437. Regina B Troyanovsky et al. (2003). "Adhesive and lateral E-cadherin dimers are mediated by the same interface".PMID 14585958
  438. Jennifer Alami et al. (2003). "Derivation and characterization of a Wilms' tumour cell line, WiT 49".PMID 14506735
  439. Nelson G Ordonez et al. (2003). "Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma".PMID 14506634
  440. J Alami et al. (2003). "Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours".PMID 12890743
  441. Jose Palacios et al. (2003). "Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast".PMID 12861063
  442. David Sarrio et al. (2003). "Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability".PMID 12800196
  443. A S Rocha et al. (2003). "E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas".PMID 12786894
  444. John K McGuire et al. (2003). "Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium".PMID 12759241
  445. Yang Luo et al. (2003). "Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus".PMID 12640032
  446. Ulla Impola et al. (2003). "Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation".PMID 12516088
  447. Philip M Carpenter et al. (2002). "Paranuaclear E-cadherin in gastric adenocarcinoma".PMID 12472282
  448. A Kuijper et al. (2002). "Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer".PMID 12354814
  449. S Damiani et al. (2002). "Malignant neoplasms infiltrating pseudoangiomatous' stromal hyperplasia of the breast: an unrecognized pathway of tumour spread".PMID 12207782
  450. Sumayah Jamal et al. (2002). "UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells".PMID 12189238
  451. Gary L Bratthauer et al. (2002). "Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias".PMID 12152161
  452. A Elzagheid et al. (2002). "Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance".PMID 12147090
  453. Nhan L Tran et al. (2002). "Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization".PMID 12095980
  454. Jong Tak Kim et al. (2002). "Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1".PMID 12065577
  455. Erik Sahai et al. (2002). "ROCK and Dia have opposing effects on adherens junctions downstream of Rho".PMID 11992112
  456. M Celeste Ferreira-Cornwell et al. (2002). "Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart".PMID 11950881
  457. Yael Hegerfeldt et al. (2002). "Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies".PMID 11929834
  458. Karen M Hajra et al. (2002). "The SLUG zinc-finger protein represses E-cadherin in breast cancer".PMID 11912130
  459. William B Laskin et al. (2002). "Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues".PMID 11900566
  460. Cyrille Schreider et al. (2002). "Integrin-mediated functional polarization of Caco-2 cells through E-cadherin--actin complexes".PMID 11861761
  461. L Gregoire et al. (2001). "Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro".PMID 11751530
  462. C Parker et al. (2001). "E-cadherin as a prognostic indicator in primary breast cancer".PMID 11747340
  463. K Pummi et al. (2001). "Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes".PMID 11710912
  464. J J Ascaño et al. (2001). "Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer".PMID 11598162
  465. E Kapiteijn et al. (2001). "Mechanisms of oncogenesis in colon versus rectal cancer".PMID 11592095
  466. N S Goldstein et al. (2001). "Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast".PMID 11550142
  467. M J Wheelock et al. (2001). "Cadherin junctions in mammary tumors".PMID 11547897
  468. I Barshack et al. (2001). "Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue".PMID 11533074
  469. I Noci et al. (2001). "Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide".PMID 11487260
  470. M A Rubin et al. (2001). "E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology".PMID 11486167
  471. A S Rocha et al. (2001). "Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant".PMID 11439369
  472. J S Tomlinson et al. (2001). "An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma".PMID 11431364
  473. J J Rahn et al. (2001). "The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature".PMID 11391575
  474. C J Gottardi et al. (2001). "E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner".PMID 11381089
  475. A S Leong et al. (2001). "Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems".PMID 11345835
  476. G Li et al. (2001). "N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells".PMID 11325858
  477. K M Rieger-Christ et al. (2001). "Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas".PMID 11322170
  478. J E Etzell et al. (2001). "Loss of chromosome 16q in lobular carcinoma in situ".PMID 11274638
  479. F M Waldman et al. (2001). "Genomic alterations in tubular breast carcinomas".PMID 11230710
  480. M G Rashid et al. (2001). "Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate".PMID 11212238
  481. G Acs et al. (2001). "Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications".PMID 11190811
  482. G Acs et al. (2001). "Loss of membrane expression of E-cadherin in leukemic erythroblasts".PMID 11175634
  483. Y Luo et al. (2001). "Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin".PMID 11171330
  484. L Kolby et al. (2001). "A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake".PMID 11159212
  485. P G Corn et al. (2000). "E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia".PMID 11106238
  486. O Rechardt et al. (2000). "Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines".PMID 11069614
  487. M Kaida et al. (2000). "Time at confluence for human RPE cells: effects on the adherens junction and in vitro wound closure".PMID 10967086
  488. J M Burke et al. (2000). "High levels of E-/P-cadherin: correlation with decreased apical polarity of Na/K ATPase in bovine RPE cells in situ".PMID 10845621
  489. M Y Hsu et al. (2000). "E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors".PMID 10793063
  490. K S Taraszka et al. (2000). "Molecular basis for leukocyte integrin alpha(E)beta(7) adhesion to epithelial (E)-cadherin".PMID 10790430
  491. S Halachmi et al. (2000). "Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin".PMID 10720865
  492. C J Vallorosi et al. (2000). "Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution".PMID 10652321
  493. S Mueller et al. (2000). "p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression".PMID 10646868
  494. K S Spirin et al. (1999). "Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA".PMID 10586931
  495. C Huiping et al. (1999). "Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer".PMID 10584868
  496. M D Hines et al. (1999). "Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes".PMID 10574706
  497. S Gomez et al. (1999). "Independent regulation of adherens and tight junctions by tyrosine phosphorylation in Caco-2 cells".PMID 10559465
  498. J M Burke et al. (1999). "Expression of E-cadherin by human retinal pigment epithelium: delayed expression in vitro".PMID 10549658
  499. A Peralta Soler et al. (1999). "P-cadherin expression in breast carcinoma indicates poor survival".PMID 10506713
  500. S Peltonen et al. (1999). "A novel component of epidermal cell-matrix and cell-cell contacts: transmembrane protein type XIII collagen".PMID 10504453
  501. N L Tran et al. (1999). "N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells".PMID 10487836
  502. P Blok et al. (1999). "Loss of E-cadherin expression in early gastric cancer".PMID 10231415
  503. A S Wong et al. (1999). "Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer".PMID 10188716
  504. M L Day et al. (1999). "E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway".PMID 10092652
  505. O Montonen et al. (1998). "Expression of the anhidrotic ectodermal dysplasia gene is reduced in skin cancer coinciding with reduced E-cadherin".PMID 9758413
  506. B St Croix et al. (1998). "E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)".PMID 9679152
  507. S S Kantak et al. (1998). "E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells".PMID 9642258
  508. E Sancho et al. (1998). "Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells".PMID 9418904
  509. J K Laihia et al. (1997). "Up-regulation of human epidermal Langerhans' cell B7-1 and B7-2 co-stimulatory molecules in vivo by solar-simulating irradiation".PMID 9130654
  510. I Songun et al. (1996). "Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG)".PMID 8956793
  511. L Cheng et al. (1996). "Expression of E-cadherin in primary and metastatic prostate cancer".PMID 8623909
  512. O W Rokhlin et al. (1995). "Expression of cellular adhesion molecules on human prostate tumor cell lines".PMID 7536326